FeatureID,Name,Formula,MW,KEGG.Pathways,name4plot,C,H,O,NA.,F,N,Cl,P,S,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0356,[Similar to: NP-013538; ΔMass: 86.0004 Da],C15 H18 O11,374.08493,NA,[Similar to: NP-013538; ΔMass: 86.0004 Da],15,18,11,0,0,0,0,0,0,1.2,0.733333333,0.266666667,52.7,7,-4,-1,0.157894737,-4,Other,19.02570607,24.27782979,1.276054076,0.351689468,0.076741986,0.189501295,Upregulated
Feature0437,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.16788,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak3",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,24.01806288,29.94785521,1.246888867,0.318332886,0.012863984,0.149295844,Upregulated
Feature0477,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,8,0,0,6,0,0,0,0.965517241,0.275862069,0.206896552,54.40344828,19,11,0.333333333,0.473684211,5,Phenol,25.93807154,31.94033001,1.231407276,0.300307998,0.055845443,0.171948929,Upregulated
Feature0123,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide,7,16,1,0,0,4,0,0,0,2.285714286,0.142857143,-0.285714286,68.44285714,2,1,-1.5,-1,-3,Lipid,23.72220584,29.19374918,1.230650698,0.299421333,0.007939886,0.149295844,Upregulated
Feature0297,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04739,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak3",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,26.28602053,32.08589329,1.220644762,0.287643402,0.065286345,0.177753961,Upregulated
Feature0476,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,8,0,0,6,0,0,0,1,0.266666667,0.133333333,56.5,19,11,0.3125,0.45,5,Phenol,24.3198008,29.66855808,1.219934256,0.286803401,0.020955864,0.150901486,Upregulated
Feature0438,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.1679,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak4",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,24.98430225,30.4628513,1.21927965,0.286029056,0.032483507,0.150901486,Upregulated
Feature0425,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak3",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,24.26652484,29.55222407,1.217818549,0.284299193,0.009880112,0.149295844,Upregulated
Feature0074,NA,NA,566.21535,Biosynthesis of secondary metabolites;Other,Feature0074,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.38795106,32.08657422,1.2159555,0.282090432,0.066188211,0.177753961,Upregulated
Feature0478,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,10,0,0,0,0,0,0,1.066666667,0.333333333,-0.4,71.7,15,5,0.25,0.4,5,Phenol,25.76039097,31.18175635,1.210453536,0.275547702,0.058904602,0.171994204,Upregulated
Feature0439,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid; ΔMass: -46.0418 Da]",C14 H21 N4 O5 P,356.1261,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid; ΔMass: -46.0418 Da]",14,21,5,0,0,4,0,1,0,1.5,0.357142857,-0.285714286,68.44285714,7,2,-0.75,-0.076923077,-3,Protein,24.18337002,29.22865685,1.208626292,0.273368232,0.024433197,0.150901486,Upregulated
Feature0429,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak7",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,26.18687505,31.64314474,1.208358946,0.273049075,0.063861366,0.177392683,Upregulated
Feature0252,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,0,0,0,2,0,0,0,0.833333333,0,-0.333333333,69.8,9,9,0.7,0.7,7,Unsaturated HC,22.99547279,27.77998113,1.208063056,0.272695759,0.022339295,0.150901486,Upregulated
Feature0428,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak6",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,25.62298154,30.92622501,1.206972146,0.271392383,0.051890992,0.166900853,Upregulated
Feature0073,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0073,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.89692328,29.98774827,1.204476068,0.268405729,0.030493823,0.150901486,Upregulated
Feature0435,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,402.16791,NA,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak1",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,24.04781798,28.94433746,1.203615957,0.267375139,0.035385907,0.150901486,Upregulated
Feature0427,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak5",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,25.5989599,30.79778686,1.20308743,0.266741488,0.048186079,0.161599654,Upregulated
Feature0334,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,2,0,0,1,0,0,0,2.142857143,0.285714286,-1.142857143,92.87142857,1,-1,-0.5,-0.2,-2,Lipid,23.76026649,28.51024024,1.199912478,0.262929179,0.034011279,0.150901486,Upregulated
Feature0460,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]",NA,172.07118,NA,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]-peak2",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.88265934,26.25010781,1.199584904,0.262535272,0.046629012,0.161148715,Upregulated
Feature0346,[Similar to: NP-022075; ΔMass: 142.0631 Da],C30 H32 O10,552.19968,NA,[Similar to: NP-022075; ΔMass: 142.0631 Da],30,32,10,0,0,0,0,0,0,1.066666667,0.333333333,-0.4,71.7,15,5,0.25,0.4,5,Phenol,25.91660408,31.03730212,1.197583681,0.260126468,0.071943576,0.185769798,Upregulated
Feature0289,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16794,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,23.45895375,28.05490277,1.195914493,0.258114241,0.015201031,0.149295844,Upregulated
Feature0518,NA,C30 H30 N6 O9,618.20799,NA,Feature0518,30,30,9,0,0,6,0,0,0,1,0.3,0.2,54.6,19,10,0.266666667,0.435897436,4,Phenol,22.26168167,26.60883026,1.195274941,0.25734251,0.00332645,0.149295844,Upregulated
Feature0230,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,10,0,0,0,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.227272727,0.37037037,5,Phenol,24.6628748,29.45322112,1.194233088,0.256084446,0.029800621,0.150901486,Upregulated
Feature0358,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,8,0,0,6,0,0,0,0.888888889,0.296296296,0.37037037,49.74444444,19,11,0.384615385,0.529411765,5,Phenol,24.15189697,28.82320663,1.193413779,0.255094339,0.044219742,0.161148715,Upregulated
Feature0296,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04739,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak2",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,25.58829511,30.51382686,1.192491595,0.253979098,0.062557992,0.17644562,Upregulated
Feature0426,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak4",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,24.73044576,29.32492124,1.185782154,0.245838989,0.017570857,0.150901486,Upregulated
Feature0474,"[Similar to: (2S,3R,3aS,7aR)-2-(3,4-dimethoxyphenyl)-3a,7a-dimethoxy-3-methyl-5-(prop-2-en-1-yl)-2,3,3a,6,7,7a-hexahydro-1-benzofuran-6-one; ΔMass: 209.0692 Da]",C36 H41 N O3 P2,597.25775,NA,"[Similar to: (2S,3R,3aS,7aR)-2-(3,4-dimethoxyphenyl)-3a,7a-dimethoxy-3-methyl-5-(prop-2-en-1-yl)-2,3,3a,6,7,7a-hexahydro-1-benzofuran-6-one; ΔMass: 209.0692 Da]",36,41,3,0,0,1,0,2,0,1.138888889,0.083333333,-1.166666667,93.55,18,15,0.4,0.428571429,12,Unsaturated HC,23.25694777,27.49819828,1.182364881,0.241675324,0.013988668,0.149295844,Upregulated
Feature0269,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,0,0,0,1.142857143,0.571428571,0,60.3,4,0,0,0.4,0,Phenol,23.90846566,28.26852668,1.182364735,0.241675146,0.028151894,0.150901486,Upregulated
Feature0436,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]",C22 H26 O7,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,"[Similar to: 4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid]-peak2",22,26,7,0,0,0,0,0,0,1.181818182,0.318181818,-0.545454545,75.84545455,10,3,0.2,0.351351351,3,Phenol,23.82427088,28.11633685,1.180155186,0.238976582,0.014363776,0.149295844,Upregulated
Feature0150,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,3,0,0,0,0,0,0,1.142857143,0.428571429,-0.285714286,68.44285714,4,1,0.25,0.454545455,1,Phenol,25.07818286,29.57106339,1.179154947,0.237753309,0.092010411,0.209982265,Upregulated
Feature0315,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,6,0,0,0,0,0,0,0.947368421,0.315789474,-0.315789474,69.3,11,5,0.384615385,0.5,5,Phenol,23.61982841,27.74411043,1.174611007,0.232183062,0.032730231,0.150901486,Upregulated
Feature0547,NA,C8 H15 N O4,189.10013,NA,Feature0547,8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,24.11663191,28.32131794,1.174347979,0.231859966,0.031881247,0.150901486,Upregulated
Feature0423,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak1",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,23.29027417,27.33918834,1.173845707,0.231242789,0.004526424,0.149295844,Upregulated
Feature0044,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0044,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.27529127,27.30975458,1.173336749,0.230617127,0.0107101,0.149295844,Upregulated
Feature0424,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"[Similar to: 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole]-peak2",11,12,3,0,0,0,0,0,0,1.090909091,0.272727273,-0.545454545,75.84545455,6,3,0.375,0.473684211,3,Phenol,24.21952611,28.41594797,1.17326606,0.230530208,0.047758619,0.161148715,Upregulated
Feature0488,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,6,0,0,0,0,0,0,1,0.3,-0.4,71.7,11,5,0.357142857,0.470588235,5,Phenol,24.2383281,28.40626311,1.171956374,0.228918867,0.029397469,0.150901486,Upregulated
Feature0514,NA,C35 H63 N O3,545.48106,NA,Feature0514,35,63,3,0,0,1,0,0,0,1.8,0.085714286,-1.542857143,104.2714286,5,2,0.032258065,0.076923077,1,Lipid,21.99067566,25.72303789,1.169724764,0.226169104,0.05819593,0.171994204,Upregulated
Feature0271,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,3,0,0,0,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.692307692,3,Condensed HC,23.24307545,27.16305997,1.168651714,0.224845037,0.031010016,0.150901486,Upregulated
Feature0148,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,4,0,0,0,0,0,0,1.272727273,0.363636364,-0.545454545,75.84545455,5,1,0.142857143,0.333333333,1,Phenol,23.39618825,27.33286355,1.168261396,0.22436311,0.036773622,0.15207137,Upregulated
Feature0039,NA,NA,792.22295,NA,Feature0039,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.40659889,25.00326371,1.16801664,0.224060828,0.11102096,0.231293666,Upregulated
Feature0302,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,10,0,0,0,0,0,0,1.034482759,0.344827586,-0.344827586,70.12758621,15,5,0.263157895,0.416666667,5,Phenol,24.96535702,29.15145303,1.167676192,0.223640257,0.054657507,0.17110782,Upregulated
Feature0144,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,3,0,0,0,0,0,0,1,0.3,-0.4,71.7,6,3,0.428571429,0.529411765,3,Phenol,24.40275326,28.45737832,1.16615441,0.221758827,0.03558658,0.150901486,Upregulated
Feature0510,NA,C18 H19 F3 N2,283.12969,NA,Feature0510,18,19,0,0,3,2,0,0,0,1.055555556,0,-0.722222222,80.88333333,10.5,10.5,0.53125,0.53125,8.5,Unsaturated HC,22.69870621,26.41124785,1.163557412,0.218542398,0.055065608,0.17110782,Upregulated
Feature0283,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,10,0,0,1,0,0,0,1.137931034,0.344827586,-0.344827586,70.12758621,14,4,0.166666667,0.347826087,3,Phenol,23.63825549,27.48422242,1.162700963,0.217480095,0.051229133,0.165741313,Upregulated
Feature0042,NA,NA,243.07186,NA,Feature0042,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.96947768,24.36402822,1.161880548,0.216461754,0.012946216,0.149295844,Upregulated
Feature0290,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21536,Biosynthesis of secondary metabolites;Other,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",31,34,10,0,0,0,0,0,0,1.096774194,0.322580645,-0.451612903,73.17096774,15,5,0.238095238,0.384615385,5,Phenol,23.76492673,27.60946359,1.161773563,0.216328905,0.023558685,0.150901486,Upregulated
Feature0336,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,7,0,0,0,0,0,0,1.142857143,0.333333333,-0.476190476,73.87142857,10,3,0.214285714,0.371428571,3,Phenol,23.94232338,27.69878177,1.156896151,0.210259367,0.029692446,0.150901486,Upregulated
Feature0020,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,4,0,0,2,0,0,0,1.2,0.4,0.2,54.6,6,2,0,0.333333333,0,Phenol,22.78482209,26.286683,1.153692704,0.206259001,0.0465104,0.161148715,Upregulated
Feature0059,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0059,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.37748682,28.09129876,1.152345973,0.204573927,0.036280066,0.15207137,Upregulated
Feature0109,NP-013538 mzCloud,C12 H16 O8,288.08457,NA,NP-013538 mzCloud-peak2,12,16,8,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,5,-3,-0.75,0.125,-3,Other,23.67103681,27.2653166,1.151842939,0.203944009,0.054822113,0.17110782,Upregulated
Feature0277,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,3,0,0,1,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,24.26746049,27.94306422,1.151462232,0.203467091,0.030277329,0.150901486,Upregulated
Feature0408,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]",C11 H14 N4 O2,234.11165,NA,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]-peak1",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,23.3949903,26.81253072,1.14608001,0.196707765,0.046113254,0.161148715,Upregulated
Feature0058,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0058,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.35064775,27.87099075,1.144568762,0.194804138,0.064843474,0.177753961,Upregulated
Feature0051,NA,NA,178.06303,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Feature0051,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.94280465,27.39635465,1.144241665,0.194391783,0.035667624,0.150901486,Upregulated
Feature0295,"3,4-Dihydroxyphenylpropionic acid",C9 H10 O4,164.04738,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other","3,4-Dihydroxyphenylpropionic acid-peak1",9,10,4,0,0,0,0,0,0,1.111111111,0.444444444,-0.222222222,66.63333333,5,1,0.2,0.428571429,1,Phenol,25.15684401,28.75497766,1.143028022,0.192860773,0.082387203,0.197873194,Upregulated
Feature0464,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,5,0,0,6,0,0,0,0.888888889,0.277777778,0.666666667,41.3,14,9,0.428571429,0.578947368,3,Phenol,23.55497253,26.74294805,1.135341933,0.183126862,0.100718777,0.21809184,Upregulated
Feature0185,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,23.28491792,26.42241251,1.13474364,0.182366402,0.004754872,0.149295844,Upregulated
Feature0263,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,4,0,0,1,0,0,0,1.888888889,0.444444444,-0.666666667,79.3,2,-2,-0.75,-0.166666667,-3,Protein,24.44595765,27.71585602,1.13376029,0.181115644,0.025812667,0.150901486,Upregulated
Feature0260,Adenosine isomer,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine isomer,10,13,4,0,0,5,0,0,0,1.3,0.4,1,31.8,7,3,-2,0,-2,Phenol,25.5066118,28.89535025,1.132857256,0.179966088,0.030291964,0.150901486,Upregulated
Feature0504,NA,C12 H23 N O4,245.16269,NA,Feature0504,12,23,4,0,0,1,0,0,0,1.916666667,0.333333333,-1,88.8,2,-2,-0.428571429,-0.111111111,-3,Protein,21.99809736,24.87584387,1.130817974,0.177366719,0.014166486,0.149295844,Upregulated
Feature0181,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,4,0,0,2,0,0,1,2,0.571428571,0.285714286,52.15714286,2,-2,#NAME?,-1.5,-5,Amino Sugar,21.51826258,24.33192615,1.130757005,0.177288934,0.011995682,0.149295844,Upregulated
Feature0112,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,3,0,0,0,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.384615385,1,Phenol,23.18351185,26.14325532,1.127665881,0.173339671,0.068015738,0.178988783,Upregulated
Feature0304,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,6,0,0,1,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,2,-4,-2.5,-0.4,-5,Amino Sugar,21.42972883,24.16358722,1.127573168,0.173221052,0.074282341,0.188273216,Upregulated
Feature0363,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,9,0,0,5,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.230769231,-6,Phenol,22.2006011,25.00486151,1.126314617,0.171609876,0.10875594,0.228304454,Upregulated
Feature0216,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,4,0,0,6,0,0,1,1.636363636,0.363636364,0.909090909,34.39090909,6,2,#NAME?,-1.5,-5,Protein,21.96464097,24.72355526,1.125607074,0.170703301,0.028433216,0.150901486,Upregulated
Feature0306,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,5,0,0,1,0,0,0,1.1,0.5,0.2,54.6,6,1,0,0.384615385,0,Phenol,23.36460188,26.28321862,1.124916177,0.169817503,0.076828237,0.189501295,Upregulated
Feature0361,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,4,0,0,7,0,0,0,1.571428571,0.571428571,2.571428571,-12.98571429,6,2,1.25,1.5,-5,Amino Sugar,21.01636586,23.62191806,1.123977295,0.168612893,0.06035433,0.171994204,Upregulated
Feature0479,[Similar to: (±)5(6)-DiHET; ΔMass: -166.1745 Da],NA,172.07118,NA,[Similar to: (±)5(6)-DiHET; ΔMass: -166.1745 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.27809176,23.8756483,1.122076574,0.166171133,0.063290861,0.176700375,Upregulated
Feature0459,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]",NA,172.07118,NA,"[Similar to: 2-(2-thienyl)-1,3-thiazole-4-carboxylic acid; ΔMass: -38.9050 Da]-peak1",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.73376025,23.26073942,1.121877515,0.165915173,0.041614939,0.160057457,Upregulated
Feature0411,[Similar to: 6-Aminocaproic acid],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: 6-Aminocaproic acid]-peak2,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,22.50452463,25.22456244,1.120866264,0.164614153,4.98E-04,0.135338788,Upregulated
Feature0357,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,9,0,0,4,0,1,0,1.16,0.36,-0.16,64.86,14,5,0,0.290322581,0,Phenol,23.92838248,26.80372367,1.120164461,0.163710562,0.042862135,0.161148715,Upregulated
Feature0025,NA,NA,245.17401,NA,Feature0025,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.20864475,25.96002845,1.118549951,0.161629684,0.029754146,0.150901486,Upregulated
Feature0303,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,5,0,0,1,0,0,0,1.8,0.333333333,-0.933333333,86.9,3,-2,-0.333333333,-0.043478261,-3,Protein,20.72447876,23.13659845,1.116389884,0.158840957,0.012123807,0.149295844,Upregulated
Feature0034,NA,NA,188.06609,NA,Feature0034,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.66444984,23.06698144,1.116264,0.15867827,0.006327983,0.149295844,Upregulated
Feature0093,Penicillic acid isomer 1,C8 H10 O4,170.05554,NA,Penicillic acid isomer 1,8,10,4,0,0,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.333333333,0,Phenol,22.08609982,24.65337444,1.116239383,0.158646454,0.075449637,0.189501295,Upregulated
Feature0442,"[Similar to: 3,4-Methylenedioxy-N-propylamphetamine]",C13 H19 N O2,221.14159,NA,"[Similar to: 3,4-Methylenedioxy-N-propylamphetamine]",13,19,2,0,0,1,0,0,0,1.461538462,0.153846154,-0.923076923,86.60769231,5,3,0.2,0.272727273,2,Phenol,24.40169923,27.19708393,1.114556969,0.156470359,0.107739802,0.227911119,Upregulated
Feature0179,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13722,NA,L-gamma-Glutamyl-L-leucine,11,20,5,0,0,2,0,0,0,1.818181818,0.454545455,-0.363636364,70.66363636,3,-2,-1,-0.230769231,-4,Protein,22.21168617,24.71396278,1.11265586,0.154007442,0.15029546,0.282124584,Upregulated
Feature0320,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,0,0,0,1,0,0,0,1.761904762,0,-1.619047619,106.4428571,4,4,0.15,0.15,3,Lipid,24.88887029,27.68702174,1.112425812,0.153709125,0.134385958,0.261174123,Upregulated
Feature0544,NA,C14 H10 F N O2,221.08991,Metabolic pathways;ABC transporters;Other,Feature0544,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,22.40407275,24.88108721,1.110560901,0.151288509,0.008985006,0.149295844,Upregulated
Feature0257,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,2,0,0,3,0,0,0,1.833333333,0.333333333,0.333333333,50.8,3,1,-2,-0.5,-2,Protein,24.10437634,26.72532833,1.10873345,0.148912569,0.167506996,0.298151612,Upregulated
Feature0114,NP-003459,C9 H14 O4,168.07869,Metabolic pathways;Other,NP-003459,9,14,4,0,0,0,0,0,0,1.555555556,0.444444444,-0.666666667,79.3,3,-1,-0.2,0.142857143,-1,Protein,23.41723095,25.9544615,1.108348872,0.148412066,7.38E-04,0.135338788,Upregulated
Feature0387,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,2,0,0,8,0,2,2,2.833333333,0.166666667,-1,88.8,1,-1,6.5,12,-13,Other,23.6848074,26.18992428,1.105768936,0.145049948,0.028602939,0.150901486,Upregulated
Feature0542,NA,C23 H38 O5,376.259,NA,Feature0542,23,38,5,0,0,0,0,0,0,1.652173913,0.217391304,-1.217391304,94.99565217,5,0,0,0.12195122,0,Lipid,22.52841449,24.90655435,1.105561795,0.144779666,0.066915228,0.177753961,Upregulated
Feature0201,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,22.68916587,25.04141227,1.10367267,0.142312357,0.134288693,0.261174123,Upregulated
Feature0064,NA,NA,376.259,NA,Feature0064,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.19899917,24.47699248,1.102616937,0.140931668,0.191485099,0.331184919,Upregulated
Feature0177,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,3,0,0,2,0,0,0,2,0.6,0.4,48.9,2,-1,#NAME?,-1,-3,Amino Sugar,23.97243057,26.42447608,1.102286062,0.140498676,0.071103098,0.184465585,Upregulated
Feature0211,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,3,0,0,1,0,0,0,2.142857143,0.428571429,-0.857142857,84.72857143,1,-2,-1,-0.333333333,-3,Protein,25.33571321,27.91628721,1.101855195,0.139934638,0.094821251,0.213736427,Upregulated
Feature0548,NA,C14 H10 F N O2,243.07186,NA,Feature0548,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,20.66827903,22.72879223,1.099694474,0.137102758,0.056482638,0.171948929,Upregulated
Feature0117,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,1,0,0,2,0,0,0,1,0.166666667,0.333333333,50.8,5,4,0.666666667,0.714285714,2,Phenol,23.36641631,25.69467858,1.099641393,0.137033119,0.144588825,0.276124492,Upregulated
Feature0382,[Similar to: L-Glutamine],C5 H10 N2 O3,129.04259,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,[Similar to: L-Glutamine],5,10,3,0,0,2,0,0,0,2,0.6,0.4,48.9,2,-1,#NAME?,-1,-3,Amino Sugar,23.90575817,26.26430836,1.098660338,0.135745432,0.078126609,0.191828728,Upregulated
Feature0398,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,6,0,0,1,0,0,0,2.428571429,0.857142857,-0.285714286,68.44285714,0,-6,#NAME?,-1.333333333,-7,Carbohydrate,22.9406643,25.12654819,1.095284246,0.131305323,0.114238015,0.237097766,Upregulated
Feature0142,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,3,0,0,0,0,0,0,1.666666667,0.5,-0.666666667,79.3,2,-1,-0.333333333,0.111111111,-1,Protein,21.89246665,23.97451216,1.095103286,0.131066946,0.0172232,0.150901486,Upregulated
Feature0331,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,5,0,0,1,0,0,0,2.5,0.833333333,-0.333333333,69.8,0,-5,#NAME?,-1.4,-6,Carbohydrate,23.12638563,25.30241525,1.094092941,0.129735297,0.034621913,0.150901486,Upregulated
Feature0312,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,3,0,0,5,0,0,0,1.3,0.3,0.8,37.5,7,4,-0.5,0.142857143,-1,Phenol,24.08874137,26.32902913,1.093001445,0.128295308,0.103659535,0.221839472,Upregulated
Feature0168,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,3,0,0,1,0,0,0,1.222222222,0.333333333,-0.222222222,66.63333333,5,2,0.2,0.384615385,1,Phenol,24.32236604,26.53454936,1.090952637,0.125588469,0.186807131,0.325138994,Upregulated
Feature0223,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,4,0,0,2,0,0,0,2,0.444444444,-0.444444444,72.96666667,2,-2,-1.333333333,-0.4,-4,Protein,23.01930653,25.09821638,1.090311576,0.12474047,0.24031885,0.376567998,Upregulated
Feature0541,NA,C14 H10 F N O2,243.07186,NA,Feature0541,14,10,2,0,1,1,0,0,0,0.714285714,0.142857143,-0.214285714,66.40714286,10.5,8.5,0.681818182,0.708333333,7.5,Condensed HC,20.35326171,22.17834449,1.089670285,0.123891668,0.047323958,0.161148715,Upregulated
Feature0381,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak3,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,23.22703303,25.28973341,1.088806021,0.12274695,0.10488067,0.22271957,Upregulated
Feature0461,"[Similar to: 1,4:3,6-Dianhydro-2,5-dideoxy-2-{5-[3-(dimethylamino)phenoxy]-1H-tetrazol-1-yl}-5-[(1-naphthylcarbamoyl)amino]-L-iditol; ΔMass: -343.1569 Da]",NA,158.05552,NA,"[Similar to: 1,4:3,6-Dianhydro-2,5-dideoxy-2-{5-[3-(dimethylamino)phenoxy]-1H-tetrazol-1-yl}-5-[(1-naphthylcarbamoyl)amino]-L-iditol; ΔMass: -343.1569 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.28392074,22.07912087,1.088503606,0.122346186,0.018928946,0.150901486,Upregulated
Feature0164,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,5,0,0,2,0,0,0,1.818181818,0.454545455,-0.363636364,70.66363636,3,-2,-1,-0.230769231,-4,Protein,22.58650639,24.58457857,1.088463091,0.122292488,0.041560075,0.160057457,Upregulated
Feature0267,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,24.31726494,26.45953719,1.08809676,0.121806855,0.122100323,0.249643846,Upregulated
Feature0084,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,3,0,0,4,0,0,0,1.454545455,0.272727273,0.181818182,55.11818182,6,3,-0.25,0.090909091,-1,Phenol,22.16919433,24.03165617,1.084011255,0.116379736,0.034455754,0.150901486,Upregulated
Feature0487,(±)13-HpODE,C18 H32 O4,294.21938,Metabolic pathways;Biosynthesis of secondary metabolites;Other,(±)13-HpODE,18,32,4,0,0,0,0,0,0,1.777777778,0.222222222,-1.333333333,98.3,3,-1,-0.071428571,0.0625,-1,Lipid,20.99895401,22.69269236,1.080658224,0.11191032,0.472791151,0.613290408,Upregulated
Feature0374,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17867,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak1,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,23.07356744,24.93017018,1.080464486,0.111651653,0.090372475,0.20710359,Upregulated
Feature0171,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,6,0,0,2,0,0,0,1.818181818,0.545454545,-0.181818182,65.48181818,3,-3,-1.666666667,-0.333333333,-5,Protein,23.1661088,25.01039008,1.079611181,0.110511823,0.03294643,0.150901486,Upregulated
Feature0049,NA,NA,167.05586,NA,Feature0049,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.2309732,26.11920317,1.077926295,0.108258535,0.033489281,0.150901486,Upregulated
Feature0322,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,0,0,3,0,0,0,1.615384615,0.230769231,-0.461538462,73.45384615,5,2,-0.142857143,0.058823529,-1,Lipid,20.32889663,21.90914503,1.077734096,0.108001273,0.03653049,0.15207137,Upregulated
Feature0063,NA,NA,145.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",Feature0063,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.55675838,26.45349557,1.077238908,0.107338243,0.051205843,0.165741313,Upregulated
Feature0021,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,2,0,0,0,0,0,0,1.333333333,0.333333333,-0.666666667,79.3,3,1,0.25,0.4,1,Phenol,21.92256955,23.60857354,1.076907225,0.106893968,0.03271395,0.150901486,Upregulated
Feature0288,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,3,0,0,2,0,0,0,2,0.3,-0.8,83.1,2,-1,-0.6,-0.230769231,-3,Lipid,23.15708003,24.87866649,1.074343849,0.103455809,0.121542277,0.249643846,Upregulated
Feature0410,[Similar to: 6-Aminocaproic acid],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: 6-Aminocaproic acid]-peak1,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,21.34610781,22.91148942,1.073333351,0.102098211,0.01127552,0.149295844,Upregulated
Feature0121,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,0,0,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,23.19775296,24.89421988,1.073130657,0.10182574,0.060217627,0.171994204,Upregulated
Feature0036,NA,NA,188.06609,NA,Feature0036,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.76974449,22.28045955,1.072736333,0.101295521,0.16117645,0.29412048,Upregulated
Feature0207,DL-Tryptophan isomer 2,C11 H12 N2 O2,187.06332,Microbial metabolism in diverse environments;Other,DL-Tryptophan isomer 2,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,24.75309722,26.45640178,1.068811775,0.096007807,0.334110883,0.474834588,Upregulated
Feature0528,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0528,14,26,10,0,0,6,0,0,0,1.857142857,0.714285714,0.857142857,35.87142857,5,-5,5.5,-2,-11,Carbohydrate,22.51977951,24.06590376,1.068656278,0.0957979,0.041506445,0.160057457,Upregulated
Feature0122,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,0,0,0,6,0,0,0,1,0,0.285714286,52.15714286,11,11,0.625,0.625,5,Unsaturated HC,20.73926966,22.1586232,1.068437971,0.095503154,0.209810532,0.348627772,Upregulated
Feature0463,[Similar to: 1-methyl-3-phenyl-1H-pyrazol-5-amine; ΔMass: 115.9834 Da],C9 H18 N5 P3,289.07872,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,[Similar to: 1-methyl-3-phenyl-1H-pyrazol-5-amine; ΔMass: 115.9834 Da],9,18,0,0,0,5,0,3,0,2,0,-2,117.3,5,5,-3,-3,-3,Lipid,23.01559976,24.58009662,1.067975498,0.094878548,0.037915647,0.153335338,Upregulated
Feature0327,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,5,0,0,0,0,0,1,2.333333333,0.833333333,-0.333333333,69.8,0,-5,#NAME?,-1.4,-6,Carbohydrate,23.0713472,24.61795037,1.067035668,0.093608402,0.004056054,0.149295844,Upregulated
Feature0301,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,23.32598176,24.84746165,1.065226832,0.091160675,0.363213204,0.501050369,Upregulated
Feature0241,Cafestol,C20 H28 O3,294.21942,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Cafestol,20,28,3,0,0,0,0,0,0,1.4,0.15,-1.1,91.65,7,4,0.235294118,0.297297297,4,Phenol,23.68744654,25.20735757,1.064165254,0.089722204,0.152181125,0.284692581,Upregulated
Feature0236,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,4,0,0,1,0,0,1,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,27.96127361,29.74228808,1.063695756,0.089085563,0.133451853,0.261174123,Upregulated
Feature0399,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,4,0,0,1,0,1,0,2.8,0.8,-1.6,105.9,0,-4,6,-4,-6,Other,24.16378239,25.69767577,1.063479026,0.088791581,0.01130944,0.149295844,Upregulated
Feature0187,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,25.55468117,27.16952511,1.063191707,0.088401757,0.363423315,0.501050369,Upregulated
Feature0060,NA,NA,159.08957,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Feature0060,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.92440047,24.31506375,1.060663017,0.08496637,0.130796965,0.25784348,Upregulated
Feature0043,NA,NA,320.23285,NA,Feature0043,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.99282803,25.44741514,1.060625914,0.084915902,0.049607886,0.163068368,Upregulated
Feature0359,[Similar to: Ne-Acetyllysine],C8 H16 N2 O3,188.11612,Metabolic pathways;Other,[Similar to: Ne-Acetyllysine]-peak1,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,22.34479361,23.67959125,1.059736405,0.083705459,0.083682383,0.199126785,Upregulated
Feature0549,NA,NA,684.19664,NA,Feature0549,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.06488941,24.43823852,1.059542844,0.083441926,0.431590227,0.573368659,Upregulated
Feature0254,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,3,0,0,5,0,0,0,2.090909091,0.272727273,-0.181818182,65.48181818,3,0,-1.666666667,-0.777777778,-5,Lipid,23.20067759,24.56919352,1.058986033,0.082683561,0.021163177,0.150901486,Upregulated
Feature0022,RV0540000- ChemSpider,C5 H12 O4,136.07356,NA,RV0540000- ChemSpider,5,12,4,0,0,0,0,0,0,2.4,0.8,-0.8,83.1,0,-4,-4,-0.666666667,-4,Carbohydrate,21.00340507,22.21708792,1.057785052,0.081046493,0.086052051,0.200545033,Upregulated
Feature0550,NA,C23 H38 O5,354.27704,NA,Feature0550,23,38,5,0,0,0,0,0,0,1.652173913,0.217391304,-1.217391304,94.99565217,5,0,0,0.12195122,0,Lipid,23.72937994,25.07110181,1.056542644,0.079350998,0.255181256,0.395351242,Upregulated
Feature0520,NA,C9 H11 N O3,181.07154,NA,Feature0520,9,11,3,0,0,1,0,0,0,1.222222222,0.333333333,-0.222222222,66.63333333,5,2,0.2,0.384615385,1,Phenol,22.68330391,23.95814108,1.056201565,0.078885184,0.097235842,0.214777964,Upregulated
Feature0156,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,4,0,0,2,0,0,0,2,0.4,-0.6,77.4,2,-2,-1,-0.333333333,-4,Protein,23.3855826,24.69916211,1.056170485,0.07884273,0.207208021,0.347716756,Upregulated
Feature0040,NA,NA,276.08212,NA,Feature0040,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.47264735,24.78895123,1.056078202,0.07871667,0.005365527,0.149295844,Upregulated
Feature0433,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,2,0,0,6,0,0,0,1.894736842,0.105263158,-0.736842105,81.3,5,3,-0.272727273,-0.166666667,-3,Lipid,26.24351916,27.71189162,1.055951812,0.078543999,0.133407345,0.261174123,Upregulated
Feature0166,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,0,0,1,0,0,0,2.083333333,0.083333333,-1.666666667,107.8,1,0,-0.1,-0.047619048,-1,Lipid,24.42325567,25.75600528,1.054568876,0.076653323,0.10939829,0.228779694,Upregulated
Feature0198,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,0,0,5,0,0,0,1.909090909,0.454545455,0.363636364,49.93636364,4,-1,-6,-1,-6,Protein,22.85378678,24.1006795,1.054559568,0.076640589,0.01223842,0.149295844,Upregulated
Feature0486,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,0,0,0,1.7,0.15,-1.4,100.2,4,1,0.058823529,0.135135135,1,Lipid,19.83174095,20.89983746,1.05385793,0.075680391,0.425328928,0.567793471,Upregulated
Feature0032,NA,NA,194.05553,NA,Feature0032,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.09302206,22.21064751,1.052985553,0.074485643,0.074145513,0.188273216,Upregulated
Feature0133,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide",C8 H11 N O4,185.06883,NA,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide",8,11,4,0,0,1,0,0,0,1.375,0.5,0,60.3,4,0,-0.333333333,0.2,-1,Phenol,21.77476104,22.92066774,1.052625455,0.073992188,0.032364003,0.150901486,Upregulated
Feature0141,MFCD00025555 ChemSpider,C9 H18 N2 O3,202.1317,NA,MFCD00025555 ChemSpider,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,24.25758807,25.53297596,1.052576863,0.073925588,0.282257358,0.42385007,Upregulated
Feature0379,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak1,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,23.53454679,24.75681457,1.051935046,0.073045626,0.210702397,0.349055176,Upregulated
Feature0375,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak2,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,23.35993127,24.56697178,1.051671407,0.072684007,0.022802358,0.150901486,Upregulated
Feature0035,NA,NA,233.07768,NA,Feature0035,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.32429535,24.48363875,1.049705399,0.069984491,0.005203481,0.149295844,Upregulated
Feature0543,NA,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Feature0543,5,14,6,0,0,1,0,1,0,2.8,1.2,-0.8,83.1,0,-6,2.666666667,#NAME?,-8,Other,23.63693112,24.78431085,1.048541823,0.068384408,0.122913508,0.249643846,Upregulated
Feature0515,NA,C12 H15 N3 S,233.10278,NA,Feature0515,12,15,0,0,0,3,0,0,1,1.25,0,-0.333333333,69.8,7,7,0.375,0.375,3,Unsaturated HC,19.29631704,20.22960775,1.048366261,0.06814283,0.027271491,0.150901486,Upregulated
Feature0384,[Similar to: Isoleucine],C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: Isoleucine]-peak2,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,24.33453862,25.49461607,1.047672054,0.067187191,0.515506937,0.648807358,Upregulated
Feature0490,"?,?'-diglycerol",C6 H14 O5,166.08414,NA,"?,?'-diglycerol",6,14,5,0,0,0,0,0,0,2.333333333,0.833333333,-0.666666667,79.3,0,-5,-5,-0.714285714,-5,Carbohydrate,21.88196775,22.91942592,1.047411557,0.066828429,0.275451422,0.416204072,Upregulated
Feature0494,NA,C11 H23 N3 O3,245.17392,NA,Feature0494,11,23,3,0,0,3,0,0,0,2.090909091,0.272727273,-0.727272727,81.02727273,2,-1,-0.8,-0.384615385,-4,Lipid,23.31934779,24.4127431,1.046887902,0.066106971,0.007359185,0.149295844,Upregulated
Feature0214,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,4,0,0,2,0,0,0,2,0.571428571,0,60.3,2,-2,-4,-0.666666667,-4,Amino Sugar,25.31751313,26.49025533,1.046321382,0.065326049,0.222792227,0.357247011,Upregulated
Feature0087,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid,6,11,2,0,0,1,0,0,0,1.833333333,0.333333333,-0.666666667,79.3,2,0,-0.333333333,0,-1,Protein,20.79674253,21.74533413,1.045612509,0.064348306,0.004465645,0.149295844,Upregulated
Feature0397,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,6,0,0,1,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,23.5916073,24.63673696,1.04430091,0.062537476,0.00989064,0.149295844,Upregulated
Feature0266,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20383,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,21.25189543,22.16557695,1.042992943,0.060729396,0.353144464,0.494222533,Upregulated
Feature0204,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,5,0,0,1,0,0,0,2.166666667,0.833333333,0,60.3,1,-4,#NAME?,-1,-5,Carbohydrate,23.69443508,24.70747264,1.04275424,0.060399178,0.239452571,0.376282612,Upregulated
Feature0184,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,3,0,0,2,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.666666667,-0.111111111,-2,Protein,24.87501892,25.91694389,1.041886399,0.059197983,0.102115858,0.219389539,Upregulated
Feature0055,NA,NA,334.21216,NA,Feature0055,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.77532497,22.67316814,1.041232137,0.058291745,0.022606054,0.150901486,Upregulated
Feature0146,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,3,0,0,5,0,0,0,2.111111111,0.333333333,0.222222222,53.96666667,3,0,-5,-1.4,-5,Protein,23.28504017,24.23314787,1.04071746,0.057578451,0.008827908,0.149295844,Upregulated
Feature0002,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,0,0,1,0,0,0,1.8,0.2,-0.8,83.1,2,1,0,0.142857143,0,Lipid,22.31945477,23.22794175,1.040703816,0.057559536,0.009298741,0.149295844,Upregulated
Feature0019,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,24.08467347,25.04672987,1.039944756,0.056506892,0.027705065,0.150901486,Upregulated
Feature0373,[Similar to: Maduramicin; ΔMass: -542.2962 Da],C18 H34 N2 O6,374.24339,NA,[Similar to: Maduramicin; ΔMass: -542.2962 Da],18,34,6,0,0,2,0,0,0,1.888888889,0.333333333,-0.888888889,85.63333333,3,-3,-0.5,-0.153846154,-5,Protein,21.2270227,22.07020252,1.039722001,0.056197835,0.297587352,0.441167234,Upregulated
Feature0377,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak4,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,24.61705203,25.58981281,1.03951573,0.055911589,0.084782009,0.199126785,Upregulated
Feature0505,NA,C18 H15 N3 O,289.11625,NA,Feature0505,18,15,1,0,0,3,0,0,0,0.833333333,0.055555556,-0.222222222,66.63333333,13,12,0.642857143,0.655172414,9,Unsaturated HC,23.83886502,24.77387652,1.039222148,0.055504083,0.199819031,0.342369056,Upregulated
Feature0351,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,0,0,0,10,0,0,0,0.666666667,0,4.333333333,-63.2,10,10,0,0,0,Condensed HC,25.48023052,26.47449521,1.039021024,0.055224847,0.164428766,0.296510889,Upregulated
Feature0273,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,19.86277503,20.63683755,1.038970512,0.055154709,0.155235803,0.287826315,Upregulated
Feature0341,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,6,0,0,0,0,1,0,2.6,1.2,-1.2,94.5,0,-6,3.5,-4,-7,Other,21.96877235,22.82132568,1.038807509,0.054928347,0.047746718,0.161148715,Upregulated
Feature0023,NA,NA,392.30162,NA,Feature0023,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.82699639,25.78766802,1.038694638,0.054771584,0.222779414,0.357247011,Upregulated
Feature0307,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,3,0,0,2,0,0,0,1.333333333,0.25,-0.333333333,69.8,6,3,0.142857143,0.294117647,1,Phenol,23.59381983,24.50530077,1.03863219,0.054684845,0.468172903,0.608735453,Upregulated
Feature0378,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak5,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,24.61869502,25.56929124,1.038612779,0.054657881,0.093106078,0.210733922,Upregulated
Feature0451,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 291.8420 Da]",NA,701.85643,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 291.8420 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.27719313,24.13928187,1.037035769,0.052465655,0.007469128,0.149295844,Upregulated
Feature0071,NA,NA,230.07661,NA,Feature0071,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.59071573,26.52402139,1.036470479,0.051679026,0.006188384,0.149295844,Upregulated
Feature0067,NA,NA,184.0348,NA,Feature0067,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.02450324,26.96179641,1.036015795,0.051045998,0.256008311,0.395518458,Upregulated
Feature0537,NA,C12 H12 N2 O S,232.07112,NA,Feature0537,12,12,1,0,0,2,0,0,1,1,0.083333333,-0.166666667,65.05,8,7,0.5,0.529411765,4,Unsaturated HC,25.90644927,26.80633555,1.034735995,0.049262721,0.003145259,0.149295844,Upregulated
Feature0316,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,11,0,0,0,0,1,0,2.111111111,1.222222222,-0.222222222,66.63333333,1,-10,3.666666667,-2.2,-11,Carbohydrate,23.41797206,24.22011651,1.03425337,0.048589658,0.007789547,0.149295844,Upregulated
Feature0321,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,6,0,0,1,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,25.84999504,26.73325735,1.034168761,0.048471632,0.069494006,0.181145514,Upregulated
Feature0238,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,0,0,0,1,0,0,0,2.157894737,0,-2,117.3,0,0,-0.055555556,-0.055555556,-1,Lipid,19.98503029,20.66159464,1.033853557,0.048031845,0.21490714,0.351141462,Upregulated
Feature0008,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,23.81230357,24.6063787,1.033347262,0.047325161,0.042901834,0.161148715,Upregulated
Feature0140,MFCD00025556 ChemSpider,C8 H14 N2 O5,218.09029,NA,MFCD00025556 ChemSpider,8,14,5,0,0,2,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.428571429,-4,Amino Sugar,24.41207015,25.20906969,1.032647765,0.046348237,0.044905981,0.161148715,Upregulated
Feature0163,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,3,0,0,2,0,0,0,1.466666667,0.2,-0.666666667,79.3,6,3,0.1,0.217391304,1,Phenol,23.58979814,24.35699801,1.032522528,0.046173259,0.063189875,0.176700375,Upregulated
Feature0318,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,2,0,0,6,0,0,0,1.75,0.25,1,31.8,5,3,#NAME?,-2,-3,Lipid,25.35662739,26.18058756,1.032494864,0.046134606,0.015781792,0.150901486,Upregulated
Feature0452,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 223.8546 Da]",NA,633.86902,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 223.8546 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.39332634,24.14892742,1.032299856,0.045862097,0.009310671,0.149295844,Upregulated
Feature0152,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,2,0,0,1,0,0,1,2.2,0.4,-0.4,71.7,1,-1,-3,-1,-3,Protein,23.31581596,24.05762681,1.031815779,0.045185414,0.269030626,0.410430853,Upregulated
Feature0454,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 155.8671 Da]",NA,565.88152,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 155.8671 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.8598518,24.61875023,1.031806503,0.045172444,0.004656762,0.149295844,Upregulated
Feature0010,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,3,0,0,5,0,0,0,2.090909091,0.272727273,-0.181818182,65.48181818,3,0,-1.666666667,-0.777777778,-5,Lipid,23.84708988,24.58631225,1.030998431,0.044042137,0.001851635,0.149295844,Upregulated
Feature0314,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,5,0,0,2,0,0,0,1.8,0.5,-0.2,66,3,-2,-1.333333333,-0.272727273,-4,Protein,24.09065462,24.83707995,1.03098402,0.044021972,0.046722118,0.161148715,Upregulated
Feature0004,α-Lactose,C12 H22 O11,359.14285,NA,α-Lactose,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,26.45479845,27.26288648,1.030545991,0.04340889,0.128020078,0.25419149,Upregulated
Feature0103,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,19.3480856,19.90387023,1.028725562,0.040858159,0.244532611,0.381085174,Upregulated
Feature0092,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,0,0,0,2.4,1,-0.4,71.7,0,-5,#NAME?,-1,-5,Carbohydrate,21.67930257,22.27487513,1.027471943,0.039098999,0.026791406,0.150901486,Upregulated
Feature0450,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,13,0,0,0,0,3,0,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,24.17598774,24.83773954,1.027372276,0.038959047,0.006200021,0.149295844,Upregulated
Feature0024,NA,NA,257.08995,NA,Feature0024,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.32809703,23.95965603,1.02707289,0.038538571,0.060328298,0.171994204,Upregulated
Feature0393,[Similar to: D-Raffinose],C18 H32 O16,526.15108,NA,[Similar to: D-Raffinose]-peak2,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,26.06348074,26.76082186,1.026755487,0.038092657,0.333703328,0.474834588,Upregulated
Feature0014,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,3,0,0,2,0,0,0,1.466666667,0.2,-0.666666667,79.3,6,3,0.1,0.217391304,1,Phenol,24.08748669,24.71580653,1.026084907,0.037150116,0.096196852,0.214040221,Upregulated
Feature0455,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,13,0,0,2,0,2,0,0.8,2.6,3.6,-42.3,6,-7,0.916666667,0.818181818,-11,Other,24.70517945,25.34637327,1.025953822,0.036965796,0.015129974,0.149295844,Upregulated
Feature0333,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,7,0,0,1,0,0,0,1.9,0.7,-0.2,66,2,-5,-3,-0.454545455,-6,Amino Sugar,28.9891767,29.72460952,1.025369221,0.036143497,0.098510858,0.215499206,Upregulated
Feature0394,[Similar to: D-Raffinose],C18 H32 O16,526.15103,NA,[Similar to: D-Raffinose]-peak3,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,26.88662916,27.56529083,1.025241605,0.035963931,0.086792781,0.201417847,Upregulated
Feature0160,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,6,0,0,1,0,0,0,1.7,0.6,-0.2,66,3,-3,-1.333333333,-0.166666667,-4,Amino Sugar,26.70975611,27.3812754,1.025141349,0.035822846,0.092984183,0.210733922,Upregulated
Feature0298,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,3,0,0,0,0,0,0,1.6,0.6,-0.4,71.7,2,-1,-0.5,0.142857143,-1,Amino Sugar,23.8328653,24.41521221,1.024434616,0.034827908,0.198141363,0.340555467,Upregulated
Feature0453,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,9,0,0,6,0,3,1,0.833333333,1.5,3,-25.2,9,0,0.769230769,0.647058824,-10,Other,24.97642279,25.58664859,1.024432074,0.034824328,0.027646591,0.150901486,Upregulated
Feature0421,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak2,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,22.80956435,23.36218554,1.024227608,0.034536353,0.686407764,0.801624933,Upregulated
Feature0215,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,3,0,0,0,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.230769231,-3,Protein,26.65564334,27.28342954,1.023551718,0.033584001,0.040034841,0.159559148,Upregulated
Feature0057,NA,NA,246.07154,NA,Feature0057,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.42992519,20.89767611,1.022895381,0.032658598,0.525927218,0.658906537,Upregulated
Feature0332,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,2,0,0,6,0,0,0,1.428571429,0.285714286,1.714285714,11.44285714,6,4,2,#NAME?,-2,Phenol,24.80177485,25.34776858,1.022014301,0.031415384,0.012563903,0.149295844,Upregulated
Feature0291,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,2,0,0,0,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.333333333,2,Phenol,21.40594443,21.87481718,1.021903857,0.031259471,0.502376566,0.638122659,Upregulated
Feature0159,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,0,0,1,0,0,0,1.833333333,0.055555556,-1.555555556,104.6333333,3,2,0.0625,0.090909091,1,Lipid,22.92040266,23.42142569,1.02185926,0.031196508,0.479651466,0.617818048,Upregulated
Feature0197,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,5,0,0,3,0,0,0,1.583333333,0.416666667,0,60.3,5,0,-0.75,-0.076923077,-3,Protein,23.74225857,24.24802059,1.021302186,0.030409799,0.375820979,0.511637471,Upregulated
Feature0196,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,2,0,0,6,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,20.89521138,21.33532235,1.021062767,0.030071554,0.300311737,0.443522592,Upregulated
Feature0244,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,0,0,1,0,0,0,1.545454545,0.090909091,-1.090909091,91.39090909,4,3,0.222222222,0.263157895,2,Lipid,19.22181535,19.6262059,1.021038104,0.030036707,0.386670853,0.523815195,Upregulated
Feature0046,NA,NA,318.21715,NA,Feature0046,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.82554118,22.26305934,1.020046154,0.028634431,0.20577089,0.347159477,Upregulated
Feature0350,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,0,0,0,10,0,0,0,0.666666667,0,4.333333333,-63.2,10,10,0,0,0,Condensed HC,25.11407728,25.60318861,1.019475584,0.027827224,0.024870123,0.150901486,Upregulated
Feature0458,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,4,0,0,0,0,2,1,0.363636364,0.363636364,-0.363636364,70.66363636,11,7,1,1,4,Condensed HC,23.9968071,24.46175718,1.019375498,0.027685581,0.044832514,0.161148715,Upregulated
Feature0388,[Similar to: Glycyl-L-leucine],C8 H16 N2 O3,188.11611,Metabolic pathways;Other,[Similar to: Glycyl-L-leucine],8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,23.7020415,24.15799586,1.019236924,0.027489448,0.279135695,0.42061543,Upregulated
Feature0200,Glycyl-L-leucine isomer,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine isomer,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,21.92617238,22.34287413,1.019004765,0.027160797,0.697509938,0.805946357,Upregulated
Feature0065,NA,NA,204.06093,NA,Feature0065,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.6093069,23.02645731,1.018450385,0.026375699,0.057689724,0.171994204,Upregulated
Feature0242,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,3,0,0,1,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.333333333,-0.185185185,-4,Lipid,23.13132679,23.55609198,1.018363201,0.026252192,0.848652078,0.906327462,Upregulated
Feature0319,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,0,0,0,1,0,0,0,1.761904762,0,-1.619047619,106.4428571,4,4,0.15,0.15,3,Lipid,23.27560447,23.69776791,1.018137593,0.025932543,0.904207987,0.94036793,Upregulated
Feature0037,NA,NA,240.06096,NA,Feature0037,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.05485265,25.47809104,1.016892471,0.024167133,0.147703666,0.280127642,Upregulated
Feature0457,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,6,0,0,2,0,1,1,1,2,4,-53.7,4,-2,0.857142857,0.75,-6,Other,26.88063768,27.33343138,1.016844604,0.024099221,0.031640602,0.150901486,Upregulated
Feature0107,NP-014287,C18 H32 O3,318.21712,NA,NP-014287,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,22.15687642,22.52351954,1.016547599,0.02367777,0.085003161,0.199126785,Upregulated
Feature0125,N-alpha-Acetyllysine,C8 H16 N2 O3,188.1161,Metabolic pathways;Other,N-alpha-Acetyllysine,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,24.50180495,24.88997224,1.015842395,0.02267659,0.238861786,0.376282612,Upregulated
Feature0532,NA,C11 H22 N2 O3,230.16304,NA,Feature0532,11,22,3,0,0,2,0,0,0,2,0.272727273,-0.909090909,86.20909091,2,-1,-0.5,-0.2,-3,Lipid,25.30716393,25.70746546,1.015817716,0.02264154,0.306632831,0.447342326,Upregulated
Feature0097,octadec-9-ynoic acid,C18 H32 O2,262.22971,NA,octadec-9-ynoic acid,18,32,2,0,0,0,0,0,0,1.777777778,0.111111111,-1.555555556,104.6333333,3,1,0.0625,0.117647059,1,Lipid,22.07709703,22.42220665,1.01563202,0.022377784,0.088869854,0.205371512,Upregulated
Feature0212,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,4,0,0,2,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.166666667,-1,Phenol,28.19913161,28.6217488,1.014986887,0.021461088,0.379015353,0.514712208,Upregulated
Feature0516,NA,C35 H63 N O3,545.48105,NA,Feature0516,35,63,3,0,0,1,0,0,0,1.8,0.085714286,-1.542857143,104.2714286,5,2,0.032258065,0.076923077,1,Lipid,23.48395633,23.82453567,1.014502639,0.020772618,0.897307541,0.940036472,Upregulated
Feature0535,NA,C23 H40 N2 O3,370.31962,NA,Feature0535,23,40,3,0,0,2,0,0,0,1.739130435,0.130434783,-1.217391304,94.99565217,5,2,0,0.076923077,0,Lipid,26.26975998,26.64176529,1.014160971,0.02028666,0.073035537,0.187708156,Upregulated
Feature0456,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -252.0576 Da]",NA,157.9568,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -252.0576 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.96741995,25.3164162,1.013978066,0.020026445,0.083539808,0.199126785,Upregulated
Feature0325,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,3,0,0,0,0,0,0,1.666666667,0.166666667,-1.333333333,98.3,4,1,0.066666667,0.151515152,1,Lipid,22.43596847,22.74824543,1.013918586,0.019941814,0.356895431,0.496943005,Upregulated
Feature0070,NA,NA,313.07741,NA,Feature0070,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.12609872,27.50251065,1.013876375,0.019881751,0.306306767,0.447342326,Upregulated
Feature0406,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid],C18 H28 O3,292.20382,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid]-peak1,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,20.86401599,21.15090864,1.013750596,0.019702762,0.456288664,0.598946934,Upregulated
Feature0006,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,3,0,0,2,0,0,0,1.8,0.3,-0.6,77.4,3,0,-0.4,-0.076923077,-2,Lipid,25.41140147,25.7506739,1.013351189,0.019134244,0.461794055,0.60186429,Upregulated
Feature0292,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,3,0,0,1,0,0,0,2.111111111,0.333333333,-1.111111111,91.96666667,1,-2,-0.6,-0.230769231,-3,Protein,21.50439146,21.79043495,1.013301631,0.019063688,0.525745813,0.658906537,Upregulated
Feature0149,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,7,0,0,1,0,0,0,1.363636364,0.636363636,0.181818182,55.11818182,5,-2,-1,0.076923077,-3,Phenol,27.66625085,28.02662766,1.013025864,0.018671008,0.374338934,0.510884402,Upregulated
Feature0264,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,2,0,0,1,0,0,0,1.545454545,0.181818182,-0.909090909,86.20909091,4,2,0.125,0.222222222,1,Lipid,18.94895127,19.18466966,1.012439653,0.017835918,0.671297459,0.790421483,Upregulated
Feature0138,MFCD00634809 ChemSpider,C16 H20 N2 O3,288.14736,NA,MFCD00634809 ChemSpider,16,20,3,0,0,2,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.272727273,0.36,3,Phenol,18.80183812,19.02621274,1.011933654,0.017114705,0.775041257,0.861156953,Upregulated
Feature0132,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide isomer",C8 H11 N O4,185.06882,NA,"N-[5-(1,2-Dihydroxyethyl)-3-furyl]acetamide isomer",8,11,4,0,0,1,0,0,0,1.375,0.5,0,60.3,4,0,-0.333333333,0.2,-1,Phenol,21.96405293,22.2242959,1.011848586,0.01699342,0.657923007,0.783954422,Upregulated
Feature0239,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,4,0,0,0,0,0,0,1.2,0.4,-0.4,71.7,5,1,0.166666667,0.375,1,Phenol,18.9792553,19.19604003,1.011422193,0.01638534,0.80904843,0.875943023,Upregulated
Feature0154,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,0,0,1,0,0,0,1.363636364,0.090909091,-0.909090909,86.20909091,5,4,0.333333333,0.368421053,3,Unsaturated HC,19.44492804,19.66427095,1.011280212,0.016182804,0.689072125,0.801624933,Upregulated
Feature0100,NP-020521 mzCloud,C18 H32 O3,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,NP-020521 mzCloud,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,22.54348762,22.79713416,1.011251433,0.016141747,0.713930626,0.81634479,Upregulated
Feature0161,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,3,0,0,0,0,0,0,1.6,0.6,-0.4,71.7,2,-1,-0.5,0.142857143,-1,Amino Sugar,23.30401749,23.55648308,1.010833565,0.015545476,0.746291646,0.844684338,Upregulated
Feature0533,NA,C2 H3 P S,89.96937,NA,Feature0533,2,3,0,0,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,25.87611149,26.14899546,1.010545788,0.015134691,0.180042559,0.315138631,Upregulated
Feature0495,NA,NA,581.85559,NA,Feature0495,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.25888994,24.51076221,1.010382679,0.014901812,0.10861629,0.228304454,Upregulated
Feature0186,Kanosamine,C6 H13 N O5,161.06907,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Kanosamine,6,13,5,0,0,1,0,0,0,2.166666667,0.833333333,0,60.3,1,-4,#NAME?,-1,-5,Carbohydrate,25.30428668,25.56630536,1.010354715,0.014861883,0.244587394,0.381085174,Upregulated
Feature0360,[Similar to: Ne-Acetyllysine],C8 H16 N2 O3,188.11612,Metabolic pathways;Other,[Similar to: Ne-Acetyllysine]-peak2,8,16,3,0,0,2,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.333333333,-3,Protein,25.07778014,25.33283547,1.01017057,0.014598917,0.35442835,0.494760387,Upregulated
Feature0525,NA,C18 H23 N5,309.19516,NA,Feature0525,18,23,0,0,0,5,0,0,0,1.277777778,0,-0.444444444,72.96666667,10,10,0.384615385,0.384615385,5,Unsaturated HC,24.47776438,24.72656658,1.010164417,0.014590129,0.917725294,0.94846373,Upregulated
Feature0013,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,2,0,0,1,0,0,0,1,0.285714286,0,60.3,5,3,0.5,0.6,2,Phenol,25.64689046,25.9068807,1.010137301,0.014551401,0.076004437,0.189501295,Upregulated
Feature0091,Phenacetin isomer 1,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin isomer 1,10,13,2,0,0,1,0,0,0,1.3,0.2,-0.6,77.4,5,3,0.285714286,0.375,2,Phenol,22.00456532,22.22181864,1.009873102,0.014174019,0.803589917,0.875943023,Upregulated
Feature0210,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,2,0,0,1,0,0,0,1.857142857,0.285714286,-0.857142857,84.72857143,2,0,-0.25,0,-1,Lipid,21.47968784,21.69109921,1.009842385,0.014130137,0.318611522,0.459937893,Upregulated
Feature0175,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,6,0,0,0,0,0,0,2.333333333,1,-0.333333333,69.8,0,-6,#NAME?,-1,-6,Carbohydrate,24.30809646,24.53975198,1.009529974,0.013683746,0.20545244,0.347159477,Upregulated
Feature0278,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,4,0,0,1,0,0,2,2.3,0.4,-0.8,83.1,0,-4,-2.333333333,-1,-7,Protein,24.42158236,24.65005156,1.009355217,0.013433984,0.090235202,0.20710359,Upregulated
Feature0079,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,3,0,0,1,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.272727273,0,Phenol,25.15130386,25.38211305,1.009176828,0.013178985,0.443776807,0.586724144,Upregulated
Feature0530,NA,NA,101.96297,NA,Feature0530,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.82927534,26.05642246,1.008794173,0.012631848,0.209271323,0.348627772,Upregulated
Feature0029,NA,NA,318.14293,NA,Feature0029,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.55154223,24.76143963,1.008549255,0.012281544,0.216721388,0.351612871,Upregulated
Feature0324,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,4,0,0,3,0,0,0,1.9,0.4,-0.2,66,3,-1,-1.333333333,-0.4,-4,Protein,24.56432863,24.75711944,1.007848406,0.011278654,0.410492386,0.552006875,Upregulated
Feature0323,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,3,0,0,0,0,0,0,1.6,0.2,-1.2,94.5,4,1,0.083333333,0.185185185,1,Lipid,22.65995456,22.83683146,1.007805704,0.011217527,0.460850511,0.60186429,Upregulated
Feature0523,NA,C9 H9 N O4,179.07955,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0523,9,9,4,0,0,1,0,0,0,1,0.444444444,0.222222222,53.96666667,6,2,0.25,0.5,1,Phenol,26.26337624,26.46737842,1.007767553,0.011162912,0.449148749,0.592402427,Upregulated
Feature0096,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,19.3736532,19.5225113,1.007683533,0.011042625,0.799023979,0.873684271,Upregulated
Feature0243,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,3,0,0,0,0,0,0,1.666666667,0.5,-0.666666667,79.3,2,-1,-0.333333333,0.111111111,-1,Protein,21.04307541,21.20250674,1.007576427,0.010889275,0.689397442,0.801624933,Upregulated
Feature0376,[Similar to: Leu-Leu],C12 H24 N2 O3,244.17868,Microbial metabolism in diverse environments;Other,[Similar to: Leu-Leu]-peak3,12,24,3,0,0,2,0,0,0,2,0.25,-1,88.8,2,-1,-0.428571429,-0.176470588,-3,Lipid,24.78980317,24.97681382,1.007543854,0.010842634,0.495748687,0.632625935,Upregulated
Feature0475,"[Similar to: (2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-({[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol; ΔMass: -117.0465 Da]",C6 H20 N9 O5 P,329.13228,NA,"[Similar to: (2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-({[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol; ΔMass: -117.0465 Da]",6,20,5,0,0,9,0,1,0,3.333333333,0.833333333,2,3.3,2,-3,1.444444444,1.615384615,-13,Other,24.13495765,24.31400877,1.007418746,0.010663482,0.350169603,0.493828928,Upregulated
Feature0497,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0497,9,8,17,0,0,0,0,2,2,0.888888889,1.888888889,2.222222222,-3.033333333,7,-10,1.166666667,1.571428571,-14,Other,24.38679998,24.5645715,1.007289662,0.010478612,0.196700859,0.339139413,Upregulated
Feature0407,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid],C18 H28 O3,310.21441,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid]-peak2,18,28,3,0,0,0,0,0,0,1.555555556,0.166666667,-1.222222222,95.13333333,5,2,0.133333333,0.212121212,2,Lipid,22.36770699,22.52939436,1.007228608,0.010391165,0.6875424,0.801624933,Upregulated
Feature0085,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,0,0,0,1,0,0,0,1.782608696,0,-1.652173913,107.3869565,4,4,0.136363636,0.136363636,3,Lipid,23.21944445,23.38368665,1.007073477,0.010168947,0.955132071,0.976392467,Upregulated
Feature0443,"[Similar to: 3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide]",C9 H17 N O6,235.10553,NA,"[Similar to: 3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide]",9,17,6,0,0,1,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,2,-4,-2.5,-0.4,-5,Amino Sugar,22.74553726,22.90306766,1.006925772,0.009957335,0.816317901,0.880342835,Upregulated
Feature0526,NA,C20 H32 N6 O3,404.25385,NA,Feature0526,20,32,3,0,0,6,0,0,0,1.6,0.15,-0.4,71.7,8,5,-0.090909091,0.04,-1,Lipid,20.15980799,20.29716537,1.006813427,0.009796362,0.85791074,0.912671,Upregulated
Feature0281,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,2,0,0,0,0,0,0,1.2,0.2,-0.8,83.1,5,3,0.375,0.444444444,3,Phenol,21.38700367,21.531014,1.006733544,0.009681891,0.783746131,0.86494227,Upregulated
Feature0134,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,0,0,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.638888889,0.666666667,11.5,Condensed HC,20.31100771,20.44592352,1.006642497,0.00955141,0.840212383,0.899059943,Upregulated
Feature0347,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,12,0,0,2,0,0,0,1.92,0.48,-0.72,80.82,3,-9,-1,-0.294117647,-11,Protein,18.15187224,18.26657449,1.006319031,0.009087752,0.863681788,0.915973173,Upregulated
Feature0272,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,0,0,0,1,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258065,0.532258065,16.5,Unsaturated HC,19.15600861,19.27353137,1.006135034,0.008823943,0.788317051,0.867148757,Upregulated
Feature0183,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,6,0,0,1,0,1,0,2.5,0.75,-1.25,95.925,0,-6,#NAME?,-1.666666667,-8,Carbohydrate,29.14658159,29.31051449,1.00562443,0.008091603,0.29398832,0.438193972,Upregulated
Feature0047,NA,NA,332.1964,NA,Feature0047,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.52193077,21.63307275,1.005164127,0.007431089,0.881297545,0.925026049,Upregulated
Feature0395,[Similar to: D-(+)-Maltose],C12 H22 O11,364.09814,NA,[Similar to: D-(+)-Maltose]-peak1,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,26.31751637,26.44985334,1.005028475,0.007236377,0.784738532,0.86494227,Upregulated
Feature0462,"[Similar to: 1,2,3-Tris({4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl}methyl) 2-hydroxypropane-1,2,3-tricarboxylate; ΔMass: -782.3022 Da]",NA,214.00891,NA,"[Similar to: 1,2,3-Tris({4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl}methyl) 2-hydroxypropane-1,2,3-tricarboxylate; ΔMass: -782.3022 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,28.38191324,28.52222447,1.004943685,0.007114658,0.275151632,0.416204072,Upregulated
Feature0245,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,3,0,0,6,0,0,0,4,1,4,-53.7,1,-2,1.333333333,1.444444444,-8,Other,20.70513031,20.80731971,1.004935463,0.007102854,0.899251574,0.940282064,Upregulated
Feature0527,NA,C18 H11 F3 N2,312.08214,NA,Feature0527,18,11,0,0,3,2,0,0,0,0.611111111,0,-0.277777778,68.21666667,14.5,14.5,0.78125,0.78125,12.5,Condensed HC,22.60336318,22.71489611,1.004934351,0.007101258,0.864345595,0.915973173,Upregulated
Feature0329,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,2,0,0,3,0,0,0,1.666666667,0.222222222,-0.222222222,66.63333333,4,2,-0.25,0,-1,Lipid,23.29199244,23.40599107,1.004894327,0.007043798,0.489453457,0.628970563,Upregulated
Feature0101,NP-019988 mzCloud,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988 mzCloud,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,20.25384501,20.3470697,1.004602814,0.006625222,0.872097899,0.921114604,Upregulated
Feature0016,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,2,0,0,0,0,0,0,1.6,0.4,-0.8,83.1,2,0,0,0.25,0,Protein,21.0561316,21.15197766,1.004551931,0.006552147,0.686706567,0.801624933,Upregulated
Feature0282,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,2,0,0,0,0,0,0,1,0.2,-0.6,77.4,6,4,0.5,0.555555556,4,Phenol,19.99059044,20.07643041,1.004294019,0.006181697,0.901646389,0.94036793,Upregulated
Feature0033,NA,NA,266.07009,Other,Feature0033,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.54903564,24.65421706,1.004284544,0.006168086,0.417496962,0.5600569,Upregulated
Feature0205,Furan,C4 H4 O,68.02622,Other,Furan,4,4,1,0,0,0,0,0,0,1,0.25,-0.5,74.55,3,2,0.666666667,0.714285714,2,Phenol,24.20050039,24.29842876,1.004046543,0.005826148,0.736284308,0.838418984,Upregulated
Feature0041,NA,NA,247.09328,NA,Feature0041,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.11023152,25.20725458,1.003863886,0.005563667,0.474776533,0.614416689,Upregulated
Feature0448,[Similar to: 2-Iodoamphetamine; ΔMass: -45.0581 Da],NA,215.94331,NA,[Similar to: 2-Iodoamphetamine; ΔMass: -45.0581 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.51051086,25.60824403,1.003831094,0.00551654,0.532994948,0.664732929,Upregulated
Feature0511,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0511,3,2,18,0,0,4,0,0,2,0.666666667,6,16.66666667,-414.7,5,-13,0.904761905,0.833333333,-19,Other,25.19478192,25.28989728,1.003775201,0.005436208,0.549683634,0.679384267,Upregulated
Feature0372,[Similar to: Maltitol; ΔMass: -198.0740 Da],NA,146.0579,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Degradation of aromatic compounds;Other,[Similar to: Maltitol; ΔMass: -198.0740 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.42408583,21.50441369,1.003749418,0.005399152,0.710315173,0.814610203,Upregulated
Feature0155,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,4,0,0,0,0,0,0,1,0.4,-0.2,66,6,2,0.333333333,0.5,2,Phenol,20.22015772,20.2959531,1.003748506,0.00539784,0.914744222,0.947475183,Upregulated
Feature0088,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,2,0,0,0,0,0,0,1.666666667,0.111111111,-1.444444444,101.4666667,4,2,0.125,0.176470588,2,Lipid,22.30999174,22.38268373,1.003258271,0.004693049,0.751086944,0.844684338,Upregulated
Feature0449,[Similar to: 2-Iodoamphetamine; ΔMass: -27.0476 Da],NA,233.95388,NA,[Similar to: 2-Iodoamphetamine; ΔMass: -27.0476 Da],0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.92051894,25.99954406,1.003048748,0.004391722,0.616431767,0.743503227,Upregulated
Feature0222,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,5,0,0,1,0,0,0,1.888888889,0.555555556,-0.444444444,72.96666667,2,-3,-1.333333333,-0.272727273,-4,Amino Sugar,24.23160926,24.30063587,1.002848619,0.004103846,0.772170015,0.859703458,Upregulated
Feature0396,[Similar to: D-(+)-Maltose],C12 H22 O11,364.09813,NA,[Similar to: D-(+)-Maltose]-peak2,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,27.69068084,27.7688744,1.002823822,0.004068173,0.595266836,0.724329115,Upregulated
Feature0522,NA,C19 H20 N4 O2,318.1539,NA,Feature0522,19,20,2,0,0,4,0,0,0,1.052631579,0.105263158,-0.210526316,66.3,12,10,0.461538462,0.5,6,Unsaturated HC,24.5008961,24.56891535,1.002776195,0.003999653,0.697370117,0.805946357,Upregulated
Feature0285,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,2,0,0,3,0,0,0,2.2,0.4,0.4,48.9,2,0,#NAME?,-2,-3,Protein,26.30514525,26.37012281,1.002470146,0.003559274,0.672576825,0.790421483,Upregulated
Feature0113,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,4,0,0,0,0,0,0,1.7,0.2,-1.3,97.35,4,0,0,0.111111111,0,Lipid,21.39645223,21.44124791,1.002093604,0.003017274,0.940538722,0.965105032,Upregulated
Feature0206,Ergocalciferol,C28 H44 O,378.32869,NA,Ergocalciferol,28,44,1,0,0,0,0,0,0,1.571428571,0.035714286,-1.5,103.05,7,6,0.222222222,0.236363636,6,Lipid,19.87573799,19.91668042,1.00205992,0.002968779,0.968676437,0.984791202,Upregulated
Feature0509,NA,C6 H5 O13 P3,377.89309,NA,Feature0509,6,5,13,0,0,0,0,3,0,0.833333333,2.166666667,1,31.8,6,-7,1,1,-10,Other,24.88142868,24.93245848,1.002050919,0.002955821,0.752536956,0.844684338,Upregulated
Feature0061,NA,NA,175.08448,NA,Feature0061,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.15331687,25.18949658,1.001438367,0.002073635,0.750381775,0.844684338,Upregulated
Feature0540,NA,NA,103.99596,NA,Feature0540,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.93548278,26.97264537,1.001379689,0.001989099,0.82999291,0.891593946,Upregulated
Feature0340,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,5,0,0,6,0,0,0,1.428571429,0.714285714,2.571428571,-12.98571429,6,1,1.25,1.666666667,-5,Other,29.54481389,29.58415613,1.001331612,0.001919833,0.749519251,0.844684338,Upregulated
Feature0503,NA,NA,100.00105,NA,Feature0503,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.48583972,24.51519166,1.001198731,0.001728367,0.792417502,0.869919413,Upregulated
Feature0062,NA,NA,360.22765,NA,Feature0062,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.96916135,20.98847898,1.00092124,0.001328457,0.978058051,0.989951677,Upregulated
Feature0056,NA,NA,283.10322,NA,Feature0056,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.65707256,26.68106058,1.000899874,0.001297661,0.856291636,0.912671,Upregulated
Feature0068,NA,NA,244.06955,Metabolic pathways;ABC transporters;Other,Feature0068,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.94574501,24.95672126,1.000440005,6.35E-04,0.991480032,0.995100299,Upregulated
Feature0118,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,1,0,0,3,0,0,0,2.333333333,0.111111111,-1.111111111,91.96666667,1,0,-0.6,-0.454545455,-3,Lipid,19.99520509,19.9997876,1.00022918,3.31E-04,0.992836128,0.995100299,Upregulated
Feature0235,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,7,0,0,0,0,0,0,1.333333333,1.166666667,1,31.8,3,-4,4,-0.2,-4,Other,29.70226148,29.69930158,0.999900348,-1.44E-04,0.982701277,0.991716885,Downregulated
Feature0498,NA,C4 H N4 O7 P3,309.90566,NA,Feature0498,4,1,7,0,0,4,0,3,0,0.25,1.75,2.5,-10.95,8,1,0.6,0.384615385,-6,Other,24.29082065,24.28706573,0.999845418,-2.23E-04,0.975331611,0.98972765,Downregulated
Feature0080,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,0,0,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,25.80585176,25.80139602,0.999827336,-2.49E-04,0.979152204,0.989951677,Downregulated
Feature0251,Beauvericin,C45 H57 N3 O9,805.39159,NA,Beauvericin,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,19.16488895,19.16143209,0.999819625,-2.60E-04,0.995388612,0.995388612,Downregulated
Feature0284,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,0,0,2,0,0,0,0.857142857,0.428571429,0.857142857,35.87142857,6,3,0.5,0.714285714,1,Phenol,20.798445,20.79065098,0.999625259,-5.41E-04,0.992678533,0.995100299,Downregulated
Feature0224,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,9,0,0,0,0,1,0,2.166666667,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,26.35562597,26.34112965,0.999449972,-7.94E-04,0.956864618,0.976392467,Downregulated
Feature0045,NA,NA,283.1032,NA,Feature0045,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.7409776,22.726659,0.999370362,-9.09E-04,0.993291026,0.995100299,Downregulated
Feature0496,NA,C3 H5 N2 P S,131.99089,NA,Feature0496,3,5,0,0,0,2,0,1,1,1.666666667,0,-0.666666667,79.3,3,3,1,1,-1,Lipid,24.13689536,24.12072633,0.999330111,-9.67E-04,0.929745016,0.957602545,Downregulated
Feature0545,NA,NA,85.98542,NA,Feature0545,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.80958334,26.78204691,0.998972889,-0.00148257,0.875574703,0.921114604,Downregulated
Feature0275,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,4,0,0,1,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,22.78129441,22.75115871,0.998677173,-0.001909699,0.835506295,0.895766983,Downregulated
Feature0539,NA,C4 H2 O8 S2,241.91814,NA,Feature0539,4,2,8,0,0,0,0,0,2,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,26.61758916,26.57569979,0.998426252,-0.002272226,0.809052828,0.875943023,Downregulated
Feature0094,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,4,0,0,0,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.333333333,0,Phenol,19.82639857,19.79109515,0.998219373,-0.002571192,0.932826074,0.958980076,Downregulated
Feature0248,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,29.96738082,29.90401777,0.997885599,-0.003053665,0.707544725,0.8141205,Downregulated
Feature0110,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,0,0,2,0,0,0,1.636363636,0.181818182,-0.727272727,81.02727273,4,2,0,0.125,0,Lipid,26.22890166,26.17312315,0.997873395,-0.003071309,0.766578467,0.856947473,Downregulated
Feature0172,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,3,0,0,1,0,0,0,1.4,0.6,0.4,48.9,3,0,-1,0.2,-1,Phenol,28.61641091,28.55264025,0.997771535,-0.003218583,0.71093254,0.814610203,Downregulated
Feature0218,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,2,0,0,1,0,0,0,1.9,0.2,-1.2,94.5,2,0,-0.142857143,0,-1,Lipid,20.26482265,20.21814383,0.997696559,-0.003326996,0.944748706,0.967619717,Downregulated
Feature0300,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,0,0,2,0,0,0,1.333333333,0.25,-0.333333333,69.8,6,3,0.142857143,0.294117647,1,Phenol,19.04141713,18.98702642,0.997143558,-0.004126872,0.919147578,0.94846373,Downregulated
Feature0402,[Similar to: Beauvericin],C45 H57 N3 O9,783.4096,NA,[Similar to: Beauvericin]-peak2,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,20.33332438,20.27416749,0.997090643,-0.004203432,0.906172733,0.94036793,Downregulated
Feature0344,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da],NA,202.04538,NA,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da]-peak2,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,29.29681305,29.21140725,0.997084809,-0.004211874,0.692383645,0.803398744,Downregulated
Feature0400,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,7,0,0,1,0,0,0,1.833333333,1.166666667,1,31.8,2,-5,3,-1.666666667,-6,Carbohydrate,28.93036261,28.84300984,0.996980585,-0.004362685,0.601349864,0.728507544,Downregulated
Feature0099,NP-021733 mzCloud,C7 H13 N O2,143.09464,ABC transporters,NP-021733 mzCloud,7,13,2,0,0,1,0,0,0,1.857142857,0.285714286,-0.857142857,84.72857143,2,0,-0.25,0,-1,Lipid,20.62189248,20.54445729,0.996245001,-0.005427516,0.873803307,0.921114604,Downregulated
Feature0227,D-(+)-Maltose,C12 H22 O11,364.09813,NA,D-(+)-Maltose,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,28.62398004,28.51500091,0.996192733,-0.005503208,0.671599231,0.790421483,Downregulated
Feature0310,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,3,0,0,2,0,0,0,1.555555556,0.333333333,-0.222222222,66.63333333,4,1,-0.25,0.090909091,-1,Protein,25.30291994,25.19041479,0.995553669,-0.006429003,0.554544727,0.683855605,Downregulated
Feature0364,[Similar to: N-Methyl-Nâ€²-piperazinoacetohydrazide],C7 H16 N4 O,172.13244,NA,[Similar to: N-Methyl-Nâ€²-piperazinoacetohydrazide],7,16,1,0,0,4,0,0,0,2.285714286,0.142857143,-0.285714286,68.44285714,2,1,-1.5,-1,-3,Lipid,24.42740829,24.31674447,0.995469687,-0.00655071,0.960689968,0.978480523,Downregulated
Feature0038,NA,NA,228.12221,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0038,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.82273387,23.71228237,0.99536361,-0.006704452,0.637237774,0.763574675,Downregulated
Feature0009,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,3,0,0,4,0,0,0,1.636363636,0.272727273,0,60.3,5,2,-0.5,-0.090909091,-2,Lipid,23.37550772,23.26084924,0.995094931,-0.007093931,0.723505163,0.825576431,Downregulated
Feature0192,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,0,0,2,0,0,0,1.2,0.4,0.8,37.5,4,2,0,0.5,0,Phenol,22.10108411,21.99016286,0.994981185,-0.00725885,0.572003321,0.703807218,Downregulated
Feature0129,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,6,0,0,1,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,22.45100988,22.33642733,0.99489633,-0.007381893,0.658521714,0.783954422,Downregulated
Feature0178,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,4,0,0,1,0,0,0,1.8,0.8,0.4,48.9,2,-2,#NAME?,-0.5,-3,Carbohydrate,28.43423089,28.28278268,0.994673736,-0.007704711,0.749867158,0.844684338,Downregulated
Feature0143,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,3,0,0,1,0,0,0,1.1,0.3,-0.2,66,6,3,0.333333333,0.466666667,2,Phenol,21.40031769,21.27922964,0.994341764,-0.008186291,0.904657757,0.94036793,Downregulated
Feature0233,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,0,0,2,0,0,0,1.142857143,0.142857143,-0.428571429,72.51428571,8,6,0.4,0.454545455,4,Phenol,26.6795906,26.51860313,0.993965894,-0.008731745,0.352301114,0.494222533,Downregulated
Feature0270,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,3,0,0,2,0,0,0,1.5,0.375,0,60.3,4,1,-0.333333333,0.111111111,-1,Protein,25.62645499,25.46848155,0.993835533,-0.008920971,0.34821881,0.49234022,Downregulated
Feature0416,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,25.03186168,24.86504836,0.99333596,-0.009646355,0.875896251,0.921114604,Downregulated
Feature0485,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,4,0,0,0,0,0,0,0.8,0.8,0.8,37.5,4,0,0,0.666666667,0,Condensed HC,25.26211038,25.08705546,0.993070456,-0.010032018,0.158945631,0.292789627,Downregulated
Feature0309,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,0,0,2,0,0,0,1.6,0.2,-0.6,77.4,4,2,0,0.142857143,0,Lipid,25.55251698,25.35631796,0.992321734,-0.011120143,0.144319721,0.276124492,Downregulated
Feature0003,α-Lactose isomer,C12 H22 O11,359.14284,NA,α-Lactose isomer,12,22,11,0,0,0,0,0,0,1.833333333,0.916666667,0,60.3,2,-9,-9,-0.538461538,-9,Carbohydrate,30.86634093,30.6284839,0.992293968,-0.011160512,0.492546139,0.630000876,Downregulated
Feature0130,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,7,0,0,1,0,0,0,1.875,0.875,0.25,53.175,2,-5,#NAME?,-0.714285714,-6,Carbohydrate,26.40696915,26.19511208,0.991977229,-0.011621091,0.625368205,0.752631319,Downregulated
Feature0052,NA,NA,235.14196,NA,Feature0052,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,21.98031642,21.80328454,0.99194589,-0.01166667,0.222331976,0.357247011,Downregulated
Feature0534,NA,C19 H20 N4 O2,336.16458,NA,Feature0534,19,20,2,0,0,4,0,0,0,1.052631579,0.105263158,-0.210526316,66.3,12,10,0.461538462,0.5,6,Unsaturated HC,25.34619845,25.13755916,0.991768419,-0.011924809,0.098629419,0.215499206,Downregulated
Feature0405,"[Similar to: 9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one]",C11 H17 N O2,195.12596,NA,"[Similar to: 9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one]",11,17,2,0,0,1,0,0,0,1.545454545,0.181818182,-0.909090909,86.20909091,4,2,0.125,0.222222222,1,Lipid,19.21450075,19.05631399,0.991767324,-0.011926402,0.80807039,0.875943023,Downregulated
Feature0213,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,2,0,0,4,0,0,0,2.333333333,0.333333333,0.333333333,50.8,2,0,#NAME?,-3,-4,Other,26.03678933,25.81960334,0.991658496,-0.01208472,0.498215707,0.634302405,Downregulated
Feature0293,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,3,0,0,0,0,0,0,1.2,0.3,-0.6,77.4,5,2,0.285714286,0.411764706,2,Phenol,17.93802367,17.78787765,0.991629734,-0.012126563,0.812030395,0.877439523,Downregulated
Feature0209,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,26.74278157,26.51631742,0.991531765,-0.012269103,0.661513547,0.784121661,Downregulated
Feature0536,NA,C11 H20 N4 O3,256.15356,NA,Feature0536,11,20,3,0,0,4,0,0,0,1.818181818,0.272727273,-0.181818182,65.48181818,4,1,-0.75,-0.272727273,-3,Lipid,18.65175382,18.4915976,0.991413343,-0.01244142,0.612746906,0.740683073,Downregulated
Feature0391,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,5,0,0,2,1,0,1,1.75,1.25,2.75,-18.075,2.5,-2.5,1.375,2,-5.5,Carbohydrate,26.79532625,26.56143638,0.991271244,-0.012648215,0.321032649,0.462219783,Downregulated
Feature0234,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,0,0,2,0,0,0,1.636363636,0.181818182,-0.727272727,81.02727273,4,2,0,0.125,0,Lipid,27.03257597,26.79048988,0.991044653,-0.012978033,0.161446856,0.29412048,Downregulated
Feature0280,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,4,0,0,0,0,0,0,2,0.8,-0.4,71.7,1,-3,-3,-0.333333333,-3,Carbohydrate,23.39176868,23.18065471,0.990974861,-0.013079636,0.067223316,0.177753961,Downregulated
Feature0105,NP-015114 mzCloud,C11 H19 N O6,278.14781,NA,NP-015114 mzCloud,11,19,6,0,0,1,0,0,0,1.727272727,0.545454545,-0.363636364,70.66363636,3,-3,-1,-0.142857143,-4,Protein,25.62667957,25.3863216,0.990620792,-0.013595194,0.58644714,0.715179439,Downregulated
Feature0390,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,4,0,0,2,1,0,1,1.25,1,2.75,-18.075,3.5,-0.5,1.166666667,1.5,-3.5,Other,25.804391,25.55998488,0.990528507,-0.0137296,0.338246061,0.479472509,Downregulated
Feature0127,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,3,0,0,1,0,0,0,1.857142857,0.428571429,-0.571428571,76.58571429,2,-1,-0.666666667,-0.111111111,-2,Protein,20.00193415,19.81036622,0.990422529,-0.013883963,0.746339113,0.844684338,Downregulated
Feature0131,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,6,0,0,1,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,25.72862457,25.46827524,0.989880947,-0.014673073,0.546191445,0.678115789,Downregulated
Feature0401,[Similar to: Beauvericin],C45 H57 N3 O9,800.43625,NA,[Similar to: Beauvericin]-peak1,45,57,9,0,0,3,0,0,0,1.266666667,0.2,-0.666666667,79.3,19,10,0.212121212,0.306666667,7,Phenol,19.37893429,19.17980309,0.989724347,-0.014901326,0.778382089,0.8631253,Downregulated
Feature0170,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,3,0,0,1,0,0,0,2.333333333,1,0.666666667,41.3,1,-2,3,-3,-3,Carbohydrate,24.74414721,24.48950768,0.989709101,-0.01492355,0.15542621,0.287826315,Downregulated
Feature0124,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,3,0,0,2,0,0,0,1.384615385,0.230769231,-0.461538462,73.45384615,6,3,0.125,0.263157895,1,Phenol,19.32299718,19.1241024,0.989706836,-0.014926852,0.771060342,0.859703458,Downregulated
Feature0027,NA,NA,241.10379,NA,Feature0027,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,19.23558537,19.03399441,0.989519895,-0.015199381,0.665987177,0.787726768,Downregulated
Feature0339,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,7,0,0,0,0,2,0,1.333333333,0.291666667,-1.166666667,93.55,10,3,0.066666667,0.243243243,1,Phenol,26.95083667,26.66716199,0.989474365,-0.015265764,0.16746406,0.298151612,Downregulated
Feature0111,NP-008521,C14 H18 N2 O2,268.1171,NA,NP-008521,14,18,2,0,0,2,0,0,0,1.285714286,0.142857143,-0.571428571,76.58571429,7,5,0.3,0.363636364,3,Phenol,19.38426275,19.17552996,0.989231843,-0.015619415,0.642777588,0.76853842,Downregulated
Feature0337,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,3,0,0,0,0,0,0,1.333333333,0.5,-0.333333333,69.8,3,0,0,0.333333333,0,Phenol,21.36724075,21.12717266,0.988764666,-0.016300906,0.269391887,0.410430853,Downregulated
Feature0413,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,25.43397536,25.13378114,0.988197117,-0.017129247,0.202172482,0.343194029,Downregulated
Feature0188,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,0,0,0,1,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,21.20788481,20.95300865,0.98798201,-0.017443323,0.781056619,0.864348371,Downregulated
Feature0265,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,0,0,5,0,0,0,1.3,0.5,1.2,26.1,7,2,#NAME?,-0.2,-3,Phenol,26.66525075,26.34280104,0.987907494,-0.017552139,0.154080121,0.287268023,Downregulated
Feature0126,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,2,0,0,3,0,0,0,1.727272727,0.181818182,-0.545454545,75.84545455,4,2,-0.166666667,0,-1,Lipid,26.36184635,26.03226944,0.987497958,-0.01815033,0.03181954,0.150901486,Downregulated
Feature0031,NA,NA,366.11403,NA,Feature0031,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,20.59247182,20.33007716,0.987257738,-0.018501324,0.630215942,0.756809537,Downregulated
Feature0174,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,0,0,2,0,0,0,2.333333333,0.333333333,-0.666666667,79.3,1,-1,-1.5,-0.666666667,-3,Other,24.30614786,23.99545762,0.987217628,-0.01855994,0.372608631,0.509787928,Downregulated
Feature0345,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,2,0,0,5,0,0,0,1.727272727,0.181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,26.94128592,26.59421948,0.987117674,-0.018706017,0.012304924,0.149295844,Downregulated
Feature0072,NA,NA,277.11616,NA,Feature0072,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,28.36342705,27.99116904,0.986875422,-0.019060117,0.065972336,0.177753961,Downregulated
Feature0030,NA,NA,281.08757,NA,Feature0030,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.60536797,25.25282938,0.986231848,-0.020001252,0.576923447,0.7066991,Downregulated
Feature0077,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,0,0,2,0,0,0,1.6,0.4,0.4,48.9,3,1,-1,0,-1,Protein,24.58444622,24.23965588,0.985975265,-0.02037664,0.311534475,0.453290903,Downregulated
Feature0208,DL-Tryptophan isomer 1,C11 H12 N2 O2,187.06332,Microbial metabolism in diverse environments;Other,DL-Tryptophan isomer 1,11,12,2,0,0,2,0,0,0,1.090909091,0.181818182,-0.181818182,65.48181818,7,5,0.428571429,0.5,3,Phenol,26.79087485,26.40602368,0.985634991,-0.020874621,0.316012437,0.458593247,Downregulated
Feature0135,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,6,0,0,1,0,0,0,1.666666667,0.666666667,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,27.32114665,26.92829876,0.985621105,-0.020894946,0.254068071,0.394738528,Downregulated
Feature0180,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,2,0,0,3,0,0,1,1.666666667,0.222222222,0,60.3,4,2,-0.666666667,-0.25,-2,Lipid,21.94942253,21.63173937,0.985526582,-0.02103331,0.512650778,0.646692495,Downregulated
Feature0082,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,8,0,0,1,0,0,0,1.5,0.8,0.4,48.9,4,-4,-5,-0.2,-5,Carbohydrate,25.61608567,25.2319131,0.985002683,-0.021800441,0.457962942,0.599713376,Downregulated
Feature0371,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,7,0,0,1,0,0,0,2.111111111,0.777777778,-0.222222222,66.63333333,1,-6,-7,-0.777777778,-7,Carbohydrate,27.81327924,27.37099726,0.984098172,-0.023125851,0.058804923,0.171994204,Downregulated
Feature0500,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0500,11,18,6,0,0,3,0,1,1,1.636363636,0.545454545,0,60.3,5,-1,#NAME?,-1,-6,Protein,20.6479155,20.31225959,0.983743835,-0.023645405,0.573386131,0.703933867,Downregulated
Feature0349,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,15,0,0,0,0,2,0,1.466666667,0.5,-0.8,83.1,10,-5,-0.538461538,0.024390244,-7,Phenol,25.36546986,24.95029378,0.983632233,-0.023809082,0.660894904,0.784121661,Downregulated
Feature0493,NA,C H3 N O5,109.00137,NA,Feature0493,1,3,5,0,0,1,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,23.85973276,23.45768668,0.983149598,-0.024517138,0.129901727,0.25699982,Downregulated
Feature0501,NA,C10 H10 N2 O2,190.06944,NA,Feature0501,10,10,2,0,0,2,0,0,0,1,0.2,0,60.3,7,5,0.5,0.571428571,3,Phenol,23.12251288,22.73026871,0.983036266,-0.024683454,0.263259171,0.405581356,Downregulated
Feature0317,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,3,0,0,1,0,0,0,1.1,0.3,-0.2,66,6,3,0.333333333,0.466666667,2,Phenol,23.98948354,23.57703545,0.982807129,-0.025019772,0.005445643,0.149295844,Downregulated
Feature0308,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,3,0,0,2,0,0,0,1.142857143,0.214285714,-0.285714286,68.44285714,8,5,0.333333333,0.428571429,3,Phenol,24.68296041,24.23689839,0.981928342,-0.02631035,0.002921218,0.149295844,Downregulated
Feature0106,NP-014287 mzCloud,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287 mzCloud,18,32,3,0,0,0,0,0,0,1.777777778,0.166666667,-1.444444444,101.4666667,3,0,0,0.090909091,0,Lipid,24.35663313,23.9107139,0.981692083,-0.026657515,0.581763825,0.711044676,Downregulated
Feature0261,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,4,0,0,5,0,0,0,1.3,0.4,1,31.8,7,3,-2,0,-2,Phenol,24.87352013,24.4109369,0.981402583,-0.027083027,0.797391808,0.873636443,Downregulated
Feature0202,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,6,0,0,0,0,1,0,3,2,-0.666666667,79.3,0,-6,1.75,4,-7,Other,22.85458839,22.42740001,0.981308419,-0.027221457,0.123006331,0.249643846,Downregulated
Feature0466,"[Similar to: [(1S,3R,13S,14S,17S,18R,19R,20S,21S,23R,24R,25S)-18,19,21-tris(acetyloxy)-24,25-dihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0Âa,Â?â°.0Âl,Â?Âl.0â·,ÂaÂ?]pentacosa-7(12),8,10-trien-20-yl]methyl acetate; ΔMass: -36.0466 Da]",NA,683.19594,NA,"[Similar to: [(1S,3R,13S,14S,17S,18R,19R,20S,21S,23R,24R,25S)-18,19,21-tris(acetyloxy)-24,25-dihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0Âa,Â?â°.0Âl,Â?Âl.0â·,ÂaÂ?]pentacosa-7(12),8,10-trien-20-yl]methyl acetate; ΔMass: -36.0466 Da]",0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.87753718,23.42720378,0.981139872,-0.027469272,0.826497935,0.889577034,Downregulated
Feature0499,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0499,9,9,6,0,0,2,0,3,4,1,0.666666667,0.222222222,53.96666667,8,2,1.166666667,1.333333333,-7,Other,24.48982434,24.02025508,0.980825944,-0.027930955,0.011246026,0.149295844,Downregulated
Feature0176,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,2,0,0,3,0,0,0,1.5,0.333333333,0.666666667,41.3,4,2,-1,0,-1,Protein,23.10423466,22.66037551,0.98078884,-0.027985532,0.31775122,0.459903082,Downregulated
Feature0195,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,0,0,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.294117647,2,Lipid,27.31620154,26.78867703,0.980688219,-0.028133549,0.507134553,0.641204608,Downregulated
Feature0415,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,26.16938651,25.66136742,0.980587276,-0.028282054,0.189493402,0.328774041,Downregulated
Feature0169,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,3,0,0,1,0,0,0,2.25,0.75,0,60.3,1,-2,#NAME?,-1,-3,Carbohydrate,25.15776433,24.6657354,0.980442263,-0.02849542,0.084520304,0.199126785,Downregulated
Feature0335,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,3,0,0,1,0,0,0,1.3,0.3,-0.4,71.7,5,2,0.166666667,0.333333333,1,Phenol,20.69085287,20.26591519,0.979462534,-0.029937786,0.530337229,0.662921537,Downregulated
Feature0513,NA,NA,257.89211,NA,Feature0513,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.15972424,24.6280692,0.978868805,-0.030812583,0.043566947,0.161148715,Downregulated
Feature0018,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,2,0,0,0,0,0,0,1,0.5,0,60.3,3,1,0.5,0.666666667,1,Phenol,26.76625049,26.19935922,0.978820669,-0.030883529,0.038643709,0.155138977,Downregulated
Feature0173,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,2,0,0,1,0,0,0,1.222222222,0.222222222,-0.444444444,72.96666667,5,3,0.333333333,0.428571429,2,Phenol,28.02292618,27.42340502,0.978606047,-0.031199897,0.324594917,0.46612847,Downregulated
Feature0480,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,9,0,0,1,0,0,0,1.7,0.9,0.4,48.9,3,-6,#NAME?,-0.555555556,-7,Carbohydrate,26.52850653,25.95459857,0.978366368,-0.031553284,0.365453569,0.501245543,Downregulated
Feature0330,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,0,0,4,0,0,0,1.692307692,0.307692308,-0.153846154,64.68461538,5,1,-0.6,-0.142857143,-3,Protein,18.94566439,18.52443757,0.977766585,-0.032437993,0.442042884,0.585839966,Downregulated
Feature0492,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0492,6,1,5,0,0,6,0,3,2,0.166666667,0.833333333,2.666666667,-15.7,11,6,0.5,0.333333333,-5,Other,24.22664529,23.6754868,0.977249905,-0.033200556,0.007369718,0.149295844,Downregulated
Feature0007,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,2,0,0,1,0,0,0,2.2,0.4,-0.8,83.1,1,-1,-1,-0.333333333,-2,Protein,26.55846893,25.94302169,0.976826705,-0.033825453,0.264835952,0.406870876,Downregulated
Feature0053,NA,NA,318.21713,NA,Feature0053,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.69785781,23.1481707,0.976804355,-0.033858463,0.504656103,0.639541144,Downregulated
Feature0484,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09545,Metabolic pathways;ABC transporters;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",9,17,8,0,0,1,0,0,0,1.888888889,0.888888889,0.222222222,53.96666667,2,-6,#NAME?,-0.75,-7,Carbohydrate,25.57192048,24.9751304,0.976662289,-0.034068302,0.123963018,0.249754199,Downregulated
Feature0417,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]-peak1",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,27.04447528,26.4065952,0.976413664,-0.034435611,0.037773998,0.153335338,Downregulated
Feature0250,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,0,0,0,1,0,0,0,1.125,0,-0.75,81.675,5,5,0.571428571,0.571428571,4,Unsaturated HC,25.33878062,24.73809515,0.976293829,-0.034612684,0.282823592,0.42385007,Downregulated
Feature0128,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,0,0,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.142857143,-1,Phenol,22.69300237,22.14671614,0.975927106,-0.0351547,0.26561754,0.406934949,Downregulated
Feature0231,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,11,0,0,4,0,2,0,1.857142857,0.785714286,-0.142857143,64.37142857,5,-6,4,-2.6,-12,Carbohydrate,22.7862697,22.23329263,0.975732005,-0.035443143,0.352486759,0.494222533,Downregulated
Feature0228,D-(+)-Glucose isomer,C6 H12 O6,197.08998,NA,D-(+)-Glucose isomer,6,12,6,0,0,0,0,0,0,2,1,0,60.3,1,-5,#NAME?,-0.666666667,-5,Carbohydrate,26.47203651,25.82515307,0.975563518,-0.035692286,0.418917162,0.560594742,Downregulated
Feature0078,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,3,0,0,0,0,0,0,1,0.5,0,60.3,4,1,0.333333333,0.555555556,1,Phenol,25.57358433,24.94856117,0.975559814,-0.035697764,0.224982801,0.359710874,Downregulated
Feature0253,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,3,0,0,2,0,0,0,2,0.75,1,31.8,2,-1,3,-3,-3,Carbohydrate,25.36108008,24.72972264,0.975105262,-0.036370129,0.149381198,0.281368696,Downregulated
Feature0353,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,7,0,0,1,0,0,0,2.5,1.166666667,0.333333333,50.8,0,-7,4,-3,-8,Carbohydrate,23.94880743,23.35255062,0.97510286,-0.036373683,0.400125777,0.540710509,Downregulated
Feature0026,NA,NA,409.15857,NA,Feature0026,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,23.67780603,23.08457205,0.974945568,-0.036606421,0.173696408,0.307180143,Downregulated
Feature0447,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,7,0,0,1,0,0,0,2.090909091,0.636363636,-0.545454545,75.84545455,1,-6,-2.333333333,-0.538461538,-7,Amino Sugar,26.67018563,25.99061976,0.974519642,-0.03723683,0.067104576,0.177753961,Downregulated
Feature0305,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,5,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,2,-3,-3,-0.142857143,-3,Carbohydrate,29.11746103,28.37490383,0.974497873,-0.037269059,0.127537851,0.254151514,Downregulated
Feature0294,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine",13,19,2,0,0,1,0,0,0,1.461538462,0.153846154,-0.923076923,86.60769231,5,3,0.2,0.272727273,2,Phenol,24.17604975,23.53687192,0.973561527,-0.038655937,0.703261767,0.81088883,Downregulated
Feature0182,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,4,0,0,1,0,0,0,1.75,1,1,31.8,2,-2,3,-1,-3,Carbohydrate,25.45437437,24.77581608,0.973342173,-0.038981029,0.034756179,0.150901486,Downregulated
Feature0444,[Similar to: 3-hydroxy-3-methylpentanedioic acid],C6 H10 O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Other,[Similar to: 3-hydroxy-3-methylpentanedioic acid],6,10,5,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,2,-3,-3,-0.142857143,-3,Carbohydrate,28.72310903,27.9528498,0.973183292,-0.039216543,0.13853544,0.268290465,Downregulated
Feature0139,MFCD00063043 ChemSpider,C11 H14 N2 O3,222.10044,NA,MFCD00063043 ChemSpider,11,14,3,0,0,2,0,0,0,1.272727273,0.272727273,-0.181818182,65.48181818,6,3,0.166666667,0.333333333,1,Phenol,23.31411783,22.68673794,0.97309013,-0.039354658,0.755310036,0.846070305,Downregulated
Feature0153,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,0,0,0,1,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,24.70590794,24.03724294,0.972935016,-0.039584647,0.220774729,0.357135591,Downregulated
Feature0521,NA,C11 H11 N3 O S,233.0664,NA,Feature0521,11,11,1,0,0,3,0,0,1,1,0.090909091,0.181818182,55.11818182,8,7,0.5,0.538461538,3,Unsaturated HC,24.18501458,23.52934885,0.972889587,-0.039652011,0.02688027,0.150901486,Downregulated
Feature0075,Pyrone isomer,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone isomer,5,4,2,0,0,0,0,0,0,0.8,0.4,0,60.3,4,2,0.666666667,0.75,2,Condensed HC,26.28734301,25.56128193,0.972379822,-0.040408138,0.046276853,0.161148715,Downregulated
Feature0482,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,4,0,0,6,0,0,0,1.5,1,5,-82.2,5,1,0.833333333,0.75,-5,Carbohydrate,29.0447983,28.23692394,0.972185231,-0.040696877,0.491364433,0.629954402,Downregulated
Feature0193,ile-his,C12 H20 N4 O3,268.15357,NA,ile-his,12,20,3,0,0,4,0,0,0,1.666666667,0.25,-0.166666667,65.05,5,2,-0.4,-0.076923077,-2,Lipid,21.72169874,21.10877798,0.971783019,-0.041293872,0.8062456,0.875943023,Downregulated
Feature0089,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,3,0,0,0,0,0,0,1,0.5,0,60.3,4,1,0.333333333,0.555555556,1,Phenol,25.93931763,25.18790966,0.971032084,-0.04240913,0.020708072,0.150901486,Downregulated
Feature0221,D-Raffinose,C18 H32 O16,526.15103,NA,D-Raffinose,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,27.24544214,26.45616973,0.971031029,-0.042410697,0.018646732,0.150901486,Downregulated
Feature0167,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,2,0,0,1,0,0,0,2.333333333,0.666666667,0,60.3,1,-1,#NAME?,-1,-2,Other,25.7199205,24.97059433,0.970865922,-0.042656024,0.101953877,0.219389539,Downregulated
Feature0203,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,4,0,0,0,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,23.82999989,23.1276785,0.970527848,-0.043158486,0.363489268,0.501050369,Downregulated
Feature0054,NA,NA,264.07224,NA,Feature0054,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.85741421,25.08543077,0.9701446,-0.043728298,0.03455137,0.150901486,Downregulated
Feature0229,D-(+)-Glucose,C6 H12 O6,197.08999,NA,D-(+)-Glucose,6,12,6,0,0,0,0,0,0,2,1,0,60.3,1,-5,#NAME?,-0.666666667,-5,Carbohydrate,30.18310184,29.27942577,0.970060199,-0.043853816,0.162568411,0.29412048,Downregulated
Feature0015,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,8,0,0,2,0,0,0,1.818181818,0.727272727,0.181818182,55.11818182,3,-5,-7,-0.6,-7,Carbohydrate,21.56707523,20.9205483,0.970022503,-0.043909879,0.096030778,0.214040221,Downregulated
Feature0348,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,18,0,0,4,0,0,0,1.6,0.72,0.32,51.18,8,-10,-4.666666667,-0.416666667,-14,Carbohydrate,27.41200108,26.58329274,0.969768411,-0.044287834,0.049809974,0.163068368,Downregulated
Feature0342,[Similar to: Tetrolic Acid]?,C4 H4 O2,84.02115,Metabolic pathways;Other,[Similar to: Tetrolic Acid]?,4,4,2,0,0,0,0,0,0,1,0.5,0,60.3,3,1,0.5,0.666666667,1,Phenol,25.81128982,25.01398655,0.969110289,-0.045267234,0.045591074,0.161148715,Downregulated
Feature0343,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da],NA,202.04537,NA,[Similar to: Scutellarioside II; ΔMass: -306.1127 Da]-peak1,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.056115,24.28191882,0.969101508,-0.045280307,0.477462203,0.616441811,Downregulated
Feature0489,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,0,0,0,2.285714286,1,-0.285714286,68.44285714,0,-7,#NAME?,-1,-7,Carbohydrate,22.25837021,21.55919895,0.968588389,-0.046044386,0.453158972,0.596261805,Downregulated
Feature0392,[Similar to: D-Raffinose],C18 H32 O16,526.15105,NA,[Similar to: D-Raffinose]-peak1,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,27.25962589,26.40290639,0.968571854,-0.046069015,0.021330253,0.150901486,Downregulated
Feature0220,D-Raffinose isomer 1,C18 H32 O16,521.19564,NA,D-Raffinose isomer 1,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,28.32633331,27.4004094,0.967312257,-0.047946415,0.021836598,0.150901486,Downregulated
Feature0286,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,1,0,0,3,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,25.79545019,24.93776505,0.966750526,-0.04878445,0.032120955,0.150901486,Downregulated
Feature0409,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]",C11 H14 N4 O2,234.11166,NA,"[Similar to: 7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione]-peak2",11,14,2,0,0,4,0,0,0,1.272727273,0.181818182,0.181818182,55.11818182,7,5,0.2,0.333333333,1,Phenol,24.62135981,23.79260554,0.966340028,-0.049397172,0.599693817,0.728105076,Downregulated
Feature0313,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,2,0,0,0,0,0,0,1.2,0.4,-0.4,71.7,3,1,0.333333333,0.5,1,Phenol,23.02018586,22.2441445,0.966288658,-0.049473867,0.139660134,0.269519556,Downregulated
Feature0246,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,10,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,3,-7,-3.5,-0.285714286,-7,Carbohydrate,26.63569784,25.71269662,0.965347211,-0.050880159,0.021064576,0.150901486,Downregulated
Feature0005,α-Eleostearic acid,C18 H30 O2,278.22457,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,2,0,0,0,0,0,0,1.666666667,0.111111111,-1.444444444,101.4666667,4,2,0.125,0.176470588,2,Lipid,23.42262799,22.60899949,0.965263142,-0.051005803,0.22744262,0.361541738,Downregulated
Feature0237,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,0,0,1,0,0,0,2.6,0.2,-1.6,105.9,0,-1,-0.666666667,-0.428571429,-2,Other,28.43779867,27.43840383,0.964856814,-0.051613234,0.065886953,0.177753961,Downregulated
Feature0011,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,0,0,2,0,0,0,1,0.5,1.5,17.55,4,2,NA,1,0,Phenol,24.33801547,23.47677811,0.964613493,-0.051977105,0.104465707,0.222698214,Downregulated
Feature0083,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,2,0,0,1,0,0,0,1.8,0.4,-0.4,71.7,2,0,-0.5,0,-1,Protein,27.82408945,26.82714618,0.964169779,-0.052640884,0.057400914,0.171994204,Downregulated
Feature0276,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,25.95083748,25.01655854,0.96399812,-0.052897762,0.030803468,0.150901486,Downregulated
Feature0412,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,6,0,0,10,0,0,0,1.272727273,0.545454545,2.545454545,-12.24545455,10,4,1.2,1.5,-6,Phenol,24.95253767,24.04787266,0.963744569,-0.05327727,0.216640044,0.351612871,Downregulated
Feature0389,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,6,0,0,0,0,1,0,2.75,1.5,-1,88.8,0,-6,2.333333333,#NAME?,-7,Other,19.38303669,18.65988324,0.962691427,-0.054854653,0.300788958,0.443522592,Downregulated
Feature0469,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,18,0,0,5,0,0,0,1.72,0.72,0.32,51.18,7,-11,-8,-0.636363636,-16,Carbohydrate,27.09779375,26.07758388,0.962350814,-0.055365187,0.056586829,0.171948929,Downregulated
Feature0491,NA,NA,121.9172,Microbial metabolism in diverse environments;Other,Feature0491,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,24.21998295,23.29792553,0.96192989,-0.055996348,0.014770118,0.149295844,Downregulated
Feature0472,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,5,0,0,6,0,0,0,0.8,0.5,2,3.3,10,5,1,1,-1,Condensed HC,19.56706106,18.81371846,0.961499451,-0.056642061,0.358559456,0.497999244,Downregulated
Feature0279,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,7,0,0,1,0,0,0,1.666666667,0.777777778,0.222222222,53.96666667,3,-4,-5,-0.333333333,-5,Carbohydrate,24.96344434,23.99483249,0.96119879,-0.057093263,0.066279656,0.177753961,Downregulated
Feature0226,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,7,0,0,0,0,0,0,2,1.166666667,0.333333333,50.8,1,-6,6,-1,-6,Carbohydrate,24.72071976,23.75151816,0.960793957,-0.057701018,0.068855495,0.18033582,Downregulated
Feature0274,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,10,0,0,1,0,0,0,1.916666667,0.833333333,0,60.3,2,-8,-9,-0.666666667,-9,Carbohydrate,26.42647163,25.38831097,0.960715124,-0.057819395,0.020078821,0.150901486,Downregulated
Feature0116,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,2,0,0,1,0,0,0,0.833333333,0.333333333,0.333333333,50.8,5,3,0.666666667,0.75,2,Phenol,24.17159036,23.21364318,0.960368881,-0.058339439,0.027168864,0.150901486,Downregulated
Feature0240,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,4,0,0,0,0,0,0,0.888888889,0.444444444,0,60.3,6,2,0.4,0.571428571,2,Phenol,19.46602722,18.69129699,0.960200907,-0.058591796,0.365210451,0.501245543,Downregulated
Feature0115,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,0,0,1.6,0,-1.6,105.9,4,4,0.266666667,0.266666667,4,Lipid,20.23138022,19.39852857,0.958833671,-0.060647522,0.303796831,0.445568685,Downregulated
Feature0352,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,4,0,0,6,0,0,0,1.6,0.8,3.6,-42.3,5,1,1,1,-5,Carbohydrate,26.61483173,25.49582768,0.957955622,-0.061969272,0.535648013,0.666530333,Downregulated
Feature0434,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,14,0,0,1,0,2,0,1.678571429,0.5,-0.928571429,86.76428571,7,-7,-0.909090909,-0.166666667,-10,Protein,26.48947337,25.33013192,0.956233881,-0.064564571,0.017327599,0.150901486,Downregulated
Feature0001,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,2,0,0,1,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,26.8289623,25.65338405,0.956182493,-0.064642104,0.001994446,0.149295844,Downregulated
Feature0473,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,3,0,0,0,0,3,0,1.727272727,0.272727273,-2.545454545,132.8454545,4,1,-0.4,-0.076923077,-2,Lipid,19.15325424,18.27176708,0.95397716,-0.067973369,0.235243325,0.371792611,Downregulated
Feature0366,[Similar to: muramic acid],C9 H17 N O7,251.10185,Metabolic pathways;ABC transporters;Other,[Similar to: muramic acid],9,17,7,0,0,1,0,0,0,1.888888889,0.777777778,0,60.3,2,-5,-6,-0.555555556,-6,Carbohydrate,24.11455332,22.99455532,0.953555101,-0.068611789,0.159171088,0.292789627,Downregulated
Feature0311,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,3,0,0,5,0,0,0,1.3,0.3,0.8,37.5,7,4,-0.5,0.142857143,-1,Phenol,22.97805742,21.90895044,0.953472699,-0.068736464,0.428065478,0.570062986,Downregulated
Feature0219,D-Raffinose isomer 2,C18 H32 O16,521.19563,NA,D-Raffinose isomer 2,18,32,16,0,0,0,0,0,0,1.777777778,0.888888889,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,27.42697396,26.14015608,0.953082032,-0.069327702,0.018287484,0.150901486,Downregulated
Feature0225,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,6,0,0,0,0,0,0,1.666666667,1,0.333333333,50.8,2,-4,#NAME?,-0.333333333,-4,Carbohydrate,23.20153184,22.1072282,0.952834854,-0.069701908,0.30223536,0.444463765,Downregulated
Feature0465,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,15,0,0,0,0,2,0,1.466666667,0.5,-0.8,83.1,10,-5,-0.538461538,0.024390244,-7,Phenol,26.57199204,25.29844073,0.952071666,-0.07085792,0.165666834,0.297767185,Downregulated
Feature0432,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,24.13478385,22.9398883,0.950490729,-0.07325554,0.123968902,0.249754199,Downregulated
Feature0403,[Similar to: AMIDINOPROLINE],C6 H11 N3 O2,157.08515,NA,[Similar to: AMIDINOPROLINE],6,11,2,0,0,3,0,0,0,1.833333333,0.333333333,0.333333333,50.8,3,1,-2,-0.5,-2,Protein,23.95086816,22.76052823,0.950300761,-0.073543911,0.549422273,0.679384267,Downregulated
Feature0069,NA,NA,310.06652,NA,Feature0069,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,27.04478778,25.63746673,0.947963317,-0.077096862,0.173283559,0.307180143,Downregulated
Feature0380,[Similar to: Leu-ala],C9 H18 N2 O3,202.1317,NA,[Similar to: Leu-ala]-peak2,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,23.43768824,22.20401401,0.947363656,-0.078009769,0.225855949,0.360060209,Downregulated
Feature0385,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,4,0,0,1,0,0,1,2.5,0.666666667,-0.333333333,69.8,0,-4,#NAME?,-2,-6,Other,18.68547375,17.69973528,0.947245733,-0.078189359,0.328512222,0.470525318,Downregulated
Feature0538,NA,C10 H19 N O8,281.11106,NA,Feature0538,10,19,8,0,0,1,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,24.83251898,23.50741276,0.946638268,-0.07911485,0.00832342,0.149295844,Downregulated
Feature0483,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,7,0,0,1,0,0,0,1.4,0.466666667,-0.266666667,67.9,6,-1,-0.285714286,0.142857143,-2,Phenol,24.65182704,23.29586083,0.944995306,-0.081620932,0.081171331,0.197873194,Downregulated
Feature0418,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"[Similar to: 5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one]-peak2",6,8,4,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,3,-1,-0.5,0.25,-1,Other,25.96514343,24.52746637,0.944630498,-0.08217798,0.049695517,0.163068368,Downregulated
Feature0247,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,10,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,3,-7,-3.5,-0.285714286,-7,Carbohydrate,28.43766025,26.85279371,0.944268744,-0.082730579,0.017280306,0.150901486,Downregulated
Feature0217,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,2,0,0,0,0,0,0,1,0.333333333,-0.333333333,69.8,4,2,0.5,0.6,2,Phenol,22.98893777,21.70185275,0.944012854,-0.083121591,0.275381469,0.416204072,Downregulated
Feature0468,"[Similar to: (3R)-4,4-Dimethyl-2-oxotetrahydro-3-furanyl beta-D-glucopyranoside; ΔMass: 49.0164 Da]",C13 H19 N5 O6,341.13224,Metabolic pathways;Other,"[Similar to: (3R)-4,4-Dimethyl-2-oxotetrahydro-3-furanyl beta-D-glucopyranoside; ΔMass: 49.0164 Da]",13,19,6,0,0,5,0,0,0,1.461538462,0.461538462,0.615384615,42.76153846,7,1,-2,-0.2,-4,Phenol,28.46289118,26.86451799,0.943843611,-0.083380261,0.017968976,0.150901486,Downregulated
Feature0414,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,5,0,0,6,0,0,0,1.75,0.625,1.75,10.425,5,0,2,7,-6,Amino Sugar,25.8328818,24.34305172,0.94232815,-0.085698553,0.214604369,0.351141462,Downregulated
Feature0355,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,14,0,0,1,0,2,0,1.678571429,0.5,-0.928571429,86.76428571,7,-7,-0.909090909,-0.166666667,-10,Protein,26.76024556,25.2163083,0.942304817,-0.085734276,0.037072594,0.152163631,Downregulated
Feature0232,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,5,0,0,3,0,0,0,1.444444444,0.555555556,0.666666667,41.3,5,0,-3,-0.142857143,-3,Phenol,24.91797915,23.47808468,0.942214637,-0.085872351,0.081309634,0.197873194,Downregulated
Feature0076,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,2,0,0,0,0,0,0,0.8,0.4,0,60.3,4,2,0.666666667,0.75,2,Condensed HC,25.59406553,24.09702111,0.941508143,-0.086954523,0.019012228,0.150901486,Downregulated
Feature0517,NA,C11 H21 N O8 S,327.09887,Other,Feature0517,11,21,8,0,0,1,0,0,1,1.909090909,0.727272727,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,24.54979569,23.10721126,0.941238435,-0.087367862,0.179494497,0.315138631,Downregulated
Feature0256,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,2,0,0,1,0,0,0,1.444444444,0.222222222,-0.666666667,79.3,4,2,0.166666667,0.285714286,1,Phenol,20.87009301,19.61865803,0.940036924,-0.08921067,0.295551239,0.439332922,Downregulated
Feature0354,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,26.30091172,24.7081082,0.939439228,-0.090128258,0.007470337,0.149295844,Downregulated
Feature0326,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,9,0,0,2,0,1,0,1.444444444,1,0.666666667,41.3,5,-4,2.333333333,-1.666666667,-7,Other,25.5555435,23.97921625,0.9383176,-0.091851768,0.177710531,0.31327177,Downregulated
Feature0524,NA,C10 H7 Cl N4,218.04022,NA,Feature0524,11,7,0,0,0,4,1,0,0,0.636363636,0,0.454545455,47.34545455,10.5,10.5,0.928571429,0.928571429,6.5,Condensed HC,23.8260656,22.35225417,0.938142895,-0.092120408,0.167371427,0.298151612,Downregulated
Feature0440,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,10,0,0,1,0,2,0,1.681818182,0.454545455,-1.090909091,91.39090909,6,-4,-0.777777778,-0.142857143,-7,Protein,21.32998983,19.97114836,0.936294321,-0.094965987,0.14303631,0.275069827,Downregulated
Feature0137,MFCD09839908 ChemSpider,C11 H16 N2 O3,224.11608,NA,MFCD09839908 ChemSpider,11,16,3,0,0,2,0,0,0,1.454545455,0.272727273,-0.363636364,70.66363636,5,2,0,0.2,0,Phenol,22.20954937,20.79107735,0.936132337,-0.095215603,0.162487446,0.29412048,Downregulated
Feature0507,NA,C10 H17 N7 O8,363.11421,NA,Feature0507,10,17,8,0,0,7,0,0,0,1.7,0.8,2,3.3,6,-2,1.8,5,-9,Carbohydrate,24.99026643,23.39045218,0.935982505,-0.095446531,0.046918436,0.161148715,Downregulated
Feature0191,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,2,0,0,1,0,0,0,0.9,0.2,-0.2,66,7,5,0.571428571,0.625,4,Phenol,21.24386565,19.87424854,0.935528819,-0.096145999,0.060151172,0.171994204,Downregulated
Feature0017,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,0,0,2,0,0,0,1.2,0.4,0.8,37.5,4,2,0,0.5,0,Phenol,23.59963778,22.03674513,0.933774719,-0.098853565,0.082317402,0.197873194,Downregulated
Feature0249,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,15,0,0,0,0,0,0,1.666666667,0.833333333,0,60.3,4,-11,-3.666666667,-0.333333333,-11,Carbohydrate,25.37348632,23.6525355,0.932175232,-0.101326914,0.057138873,0.171994204,Downregulated
Feature0162,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,3,0,0,2,0,0,0,1.818181818,0.272727273,-0.727272727,81.02727273,3,0,-0.333333333,-0.066666667,-2,Lipid,25.24255135,23.48914354,0.930537616,-0.103863624,0.207901984,0.347716756,Downregulated
Feature0512,NA,C18 H34 N2 O12,470.2113,NA,Feature0512,18,34,12,0,0,2,0,0,0,1.888888889,0.666666667,-0.222222222,66.63333333,3,-9,-2.75,-0.5,-11,Amino Sugar,24.87022299,23.1287948,0.92997939,-0.104729351,0.096396867,0.214040221,Downregulated
Feature0157,Maltotetraose,C24 H42 O21,688.20401,NA,Maltotetraose,24,42,21,0,0,0,0,0,0,1.75,0.875,0,60.3,4,-17,-5.666666667,-0.481481481,-17,Carbohydrate,26.31004479,24.38252764,0.926738355,-0.109766012,0.214824864,0.351141462,Downregulated
Feature0095,Palmitic Acid,C16 H32 O2,273.2668,NA,Palmitic Acid,16,32,2,0,0,0,0,0,0,2,0.125,-1.75,110.175,1,-1,-0.071428571,0,-1,Lipid,25.0938581,23.19738518,0.924424817,-0.113372104,0.229950685,0.364475149,Downregulated
Feature0420,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak1,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,22.09780269,20.30480633,0.918860875,-0.122081655,0.035146727,0.150901486,Downregulated
Feature0529,NA,C18 H25 N5 O10,471.15896,NA,Feature0529,18,25,10,0,0,5,0,0,0,1.388888889,0.555555556,0.555555556,44.46666667,9,-1,-2,-0.125,-6,Phenol,24.74059181,22.69606791,0.917361561,-0.124437638,0.041433652,0.160057457,Downregulated
Feature0431,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,17,0,0,5,0,0,0,1.64,0.68,0.32,51.18,8,-9,-4.666666667,-0.47826087,-14,Amino Sugar,25.64659442,23.48464817,0.915702404,-0.127049284,0.01187485,0.149295844,Downregulated
Feature0151,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,3,0,0,1,0,0,1,2.2,0.6,0,60.3,1,-2,#NAME?,-1.666666667,-4,Amino Sugar,23.8262823,21.80831319,0.91530491,-0.127675675,0.16219233,0.29412048,Downregulated
Feature0546,NA,C19 H22 Cl2 N6 O,420.12438,NA,Feature0546,20,22,1,0,0,6,2,0,0,1.1,0.05,-0.1,63.15,13,12,0.461538462,0.481481481,6,Unsaturated HC,26.91722123,24.61267763,0.914384045,-0.129127864,0.116861124,0.241630144,Downregulated
Feature0255,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,3,0,0,5,0,0,0,1.533333333,0.2,-0.133333333,64.1,7,4,-0.142857143,0.058823529,-1,Lipid,23.63381382,21.60523342,0.914166185,-0.12947164,0.401535182,0.541285172,Downregulated
Feature0441,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,12,0,0,1,0,0,0,2.083333333,1,0.166666667,55.55,1,-11,12,-1.2,-12,Carbohydrate,23.36887503,21.35788834,0.913945935,-0.12981927,0.099995938,0.217382474,Downregulated
Feature0369,[Similar to: methyl N-acetylneuraminate],C12 H21 N O9,323.12167,NA,[Similar to: methyl N-acetylneuraminate]-peak1,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,25.4945171,23.27753476,0.913040818,-0.131248736,0.058837953,0.171994204,Downregulated
Feature0028,NA,NA,300.14337,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0028,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.36183753,20.37391232,0.911101885,-0.134315701,0.021255745,0.150901486,Downregulated
Feature0136,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,7,0,0,1,0,0,0,1.888888889,0.777777778,0,60.3,2,-5,-6,-0.555555556,-6,Carbohydrate,25.796435,23.50219487,0.911063675,-0.134376206,0.056503027,0.171948929,Downregulated
Feature0119,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,2,0,0,4,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,23.17568815,21.02866476,0.907358807,-0.14025493,0.015051696,0.149295844,Downregulated
Feature0259,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,0,0,0,4,0,0,0,2.8,0,-0.4,71.7,1,1,-3,-3,-3,Other,22.99011024,20.82364591,0.905765379,-0.142790699,0.207997841,0.347716756,Downregulated
Feature0338,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,13,0,0,1,0,0,0,1.823529412,0.764705882,-0.117647059,63.65294118,3,-10,-3.666666667,-0.473684211,-11,Carbohydrate,25.65075043,23.18828863,0.904000399,-0.145604685,0.075533149,0.189501295,Downregulated
Feature0362,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,5,0,0,9,0,0,0,1.117647059,0.294117647,1.058823529,30.12352941,13,8,-0.333333333,0.272727273,-1,Phenol,21.74765159,19.61864072,0.902103873,-0.148634533,0.289441311,0.432588916,Downregulated
Feature0199,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,1,0,0,5,0,0,0,1,0.2,2.4,-8.1,6,5,0,-1,0,Phenol,22.71946998,20.40328049,0.898052662,-0.155128048,0.21515395,0.351141462,Downregulated
Feature0502,NA,C39 H74 N2 O6,666.55504,NA,Feature0502,39,74,6,0,0,2,0,0,0,1.897435897,0.153846154,-1.435897436,101.2230769,4,-2,-0.129032258,-0.029411765,-4,Lipid,22.74365847,20.36452593,0.895393587,-0.15940611,0.062003347,0.175782686,Downregulated
Feature0102,NP-019811 mzCloud,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811 mzCloud,6,7,2,0,0,1,0,0,0,1.166666667,0.333333333,0,60.3,4,2,0.333333333,0.5,1,Phenol,24.05028098,21.51497768,0.894583215,-0.160712405,0.213726734,0.351141462,Downregulated
Feature0299,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,11,0,0,1,0,0,0,1.928571429,0.785714286,-0.142857143,64.37142857,2,-9,-5,-0.6,-10,Carbohydrate,25.35978046,22.64338497,0.892885686,-0.163452613,0.059542513,0.171994204,Downregulated
Feature0050,NA,NA,297.08247,NA,Feature0050,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,26.41920213,23.5484138,0.891337054,-0.165957013,0.122750783,0.249643846,Downregulated
Feature0268,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,2,0,0,1,0,0,0,2.214285714,0.142857143,-1.714285714,109.1571429,0,-2,-0.272727273,-0.166666667,-3,Lipid,25.04532846,22.20375742,0.886542872,-0.173737695,0.047749187,0.161148715,Downregulated
Feature0158,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,0,0,3,0,0,0,2.083333333,0.25,-0.833333333,84.05,2,-1,-0.666666667,-0.333333333,-4,Lipid,24.91875365,22.0552452,0.885086209,-0.176110111,0.330829628,0.472613754,Downregulated
Feature0422,[Similar to: 4-Penten-1-amine],C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",[Similar to: 4-Penten-1-amine]-peak3,5,11,0,0,0,1,0,0,0,2.2,0,-1.6,105.9,1,1,0,0,0,Lipid,23.26370568,20.54208576,0.883010044,-0.179498247,0.011836256,0.149295844,Downregulated
Feature0165,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,0,0,1,0,0,0,2.214285714,0.071428571,-1.857142857,113.2285714,0,-1,-0.166666667,-0.12,-2,Lipid,22.66117998,20.00647424,0.882852272,-0.179756043,0.073649977,0.188273216,Downregulated
Feature0081,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,0,0,5,0,0,0,1.307692308,0.384615385,0.615384615,42.76153846,8,3,-0.666666667,0.090909091,-2,Phenol,24.19309486,21.31231886,0.880925693,-0.182907763,0.026986559,0.150901486,Downregulated
Feature0328,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,7,0,0,1,0,0,0,1.916666667,0.583333333,-0.5,74.55,2,-5,-1.5,-0.333333333,-6,Amino Sugar,26.17308642,22.89100576,0.874600931,-0.19330321,0.046989114,0.161148715,Downregulated
Feature0519,NA,C22 H23 N3 O5,431.14036,NA,Feature0519,22,23,5,0,0,3,0,0,0,1.045454545,0.227272727,-0.181818182,65.48181818,13,8,0.357142857,0.454545455,5,Phenol,24.11423198,21.01664798,0.871545401,-0.198352275,0.200480354,0.342435388,Downregulated
Feature0120,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,3,0,0,2,0,0,0,2,0.428571429,-0.285714286,68.44285714,2,-1,-1.5,-0.428571429,-3,Protein,25.01825937,21.77806422,0.870486787,-0.200105695,0.126001009,0.252921733,Downregulated
Feature0481,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,11,0,0,1,0,0,0,1.642857143,0.785714286,0.142857143,56.22857143,4,-7,-4,-0.333333333,-8,Carbohydrate,23.9350889,20.81008754,0.869438489,-0.201844131,0.098737818,0.215499206,Downregulated
Feature0287,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,3,0,0,2,0,0,0,2,0.3,-0.8,83.1,2,-1,-0.6,-0.230769231,-3,Lipid,23.74750584,20.60149562,0.8675225,-0.20502692,0.026942306,0.150901486,Downregulated
Feature0258,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,3,0,0,2,0,0,0,2,0.333333333,-0.666666667,79.3,2,-1,-0.75,-0.272727273,-3,Protein,24.11885217,20.87628504,0.865558812,-0.208296245,0.201544506,0.343187239,Downregulated
Feature0147,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,7,0,0,1,0,0,0,1.909090909,0.636363636,-0.363636364,70.66363636,2,-5,-2,-0.384615385,-6,Amino Sugar,24.45679021,21.15410575,0.864958384,-0.209297373,0.022065437,0.150901486,Downregulated
Feature0145,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,25.46375142,21.96922781,0.862764777,-0.212960816,0.149150588,0.281368696,Downregulated
Feature0108,NP-013538 mzCloud,C12 H16 O8,310.06652,NA,NP-013538 mzCloud-peak1,12,16,8,0,0,0,0,0,0,1.333333333,0.666666667,0,60.3,5,-3,-0.75,0.125,-3,Other,27.2854336,23.46535936,0.859995839,-0.217598416,0.1469046,0.279576228,Downregulated
Feature0383,[Similar to: Isoleucine],C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",[Similar to: Isoleucine]-peak1,6,13,2,0,0,1,0,0,0,2.166666667,0.333333333,-1,88.8,1,-1,-0.666666667,-0.25,-2,Protein,23.30481613,20.03960422,0.85989111,-0.217774115,0.065553575,0.177753961,Downregulated
Feature0404,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,12,0,0,1,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.333333333,-0.444444444,-10,Carbohydrate,27.52484096,23.66587368,0.859800561,-0.217926044,0.028289439,0.150901486,Downregulated
Feature0368,[Similar to: Muramic acid; ΔMass: 144.0422 Da],C16 H21 N5 O7,395.14274,NA,[Similar to: Muramic acid; ΔMass: 144.0422 Da],16,21,7,0,0,5,0,0,0,1.3125,0.4375,0.5,46.05,9,2,-0.75,0.066666667,-3,Phenol,25.2052763,21.59066741,0.856593165,-0.223317929,0.013106199,0.149295844,Downregulated
Feature0467,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,14,0,0,1,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,23.78488655,20.34546673,0.855394735,-0.225337768,0.006689195,0.149295844,Downregulated
Feature0104,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,4,0,0,2,0,0,0,1.636363636,0.363636364,-0.363636364,70.66363636,4,0,-0.4,0,-2,Protein,23.50645584,20.04352801,0.85268184,-0.229920564,0.180488489,0.315138631,Downregulated
Feature0098,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,3,0,0,1,0,0,0,2.166666667,0.5,-0.666666667,79.3,1,-2,-1.5,-0.428571429,-3,Protein,22.06981338,18.79633564,0.851676238,-0.231622996,0.126731964,0.253463928,Downregulated
Feature0446,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,8,0,0,5,0,0,0,1.526315789,0.421052632,0.105263158,57.3,8,0,-0.833333333,-0.1,-5,Protein,26.52140841,22.46787226,0.847159846,-0.239293886,0.011426198,0.149295844,Downregulated
Feature0012,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,3,0,0,1,0,0,0,2.75,0.75,-0.5,74.55,0,-3,#NAME?,-1.666666667,-4,Other,23.46083229,19.82972687,0.845226914,-0.242589389,0.052471616,0.167787144,Downregulated
Feature0506,NA,C22 H39 N O17,589.22211,NA,Feature0506,22,39,17,0,0,1,0,0,0,1.772727273,0.772727273,-0.090909091,62.89090909,4,-13,-3.5,-0.44,-14,Carbohydrate,24.84725498,20.9535062,0.843292598,-0.245894804,0.031706411,0.150901486,Downregulated
Feature0508,NA,C16 H28 N2 O13,456.15919,NA,Feature0508,16,28,13,0,0,2,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,24.06395779,20.26542784,0.842148578,-0.247853308,0.08195849,0.197873194,Downregulated
Feature0066,NA,NA,490.12991,NA,Feature0066,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,25.0512799,21.08779347,0.841785073,-0.248476168,0.096512681,0.214040221,Downregulated
Feature0090,Phenacetin isomer 2,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin isomer 2,10,13,2,0,0,1,0,0,0,1.3,0.2,-0.6,77.4,5,3,0.285714286,0.375,2,Phenol,24.81502333,20.84291808,0.839931432,-0.251656537,8.40E-05,0.046181196,Downregulated
Feature0365,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,9,0,0,5,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.230769231,-6,Phenol,23.89020327,19.86574157,0.83154343,-0.26613648,0.033564716,0.150901486,Downregulated
Feature0367,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,12,0,0,1,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,25.60934993,21.23286069,0.829105805,-0.270371874,0.016954344,0.150901486,Downregulated
Feature0531,NA,C16 H29 N O13,443.16395,NA,Feature0531,16,29,13,0,0,1,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.529411765,-11,Carbohydrate,24.58945293,20.27492692,0.824537535,-0.278342924,0.02709642,0.150901486,Downregulated
Feature0086,Pipecolic acid isomer,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid isomer,6,11,2,0,0,1,0,0,0,1.833333333,0.333333333,-0.666666667,79.3,2,0,-0.333333333,0,-1,Protein,23.46768338,19.31828023,0.823186504,-0.280708766,0.033809266,0.150901486,Downregulated
Feature0430,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,13,0,0,1,0,0,1,1.823529412,0.764705882,0,60.3,3,-10,-6,-0.647058824,-12,Carbohydrate,24.09031327,19.81580908,0.822563362,-0.281801281,0.041220181,0.160057457,Downregulated
Feature0262,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,0,0,0,5,0,0,0,1,0,2,3.3,6,6,Inf,Inf,1,Unsaturated HC,23.84108544,19.58975622,0.821680551,-0.283350476,0.076834161,0.189501295,Downregulated
Feature0445,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,12,0,0,1,0,0,0,1.476190476,0.571428571,-0.19047619,65.72857143,7,-5,-0.75,0,-6,Phenol,24.32352171,19.79072941,0.813645723,-0.297527341,0.042309919,0.161148715,Downregulated
Feature0190,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,5,0,0,4,0,0,0,1.2,0.5,1,31.8,7,2,-2,0.142857143,-2,Phenol,24.49984099,19.92951279,0.813454781,-0.297865944,0.014601111,0.149295844,Downregulated
Feature0386,[Similar to: Hypoxanthine],C5 H4 N4 O,136.03851,Metabolic pathways;Other,[Similar to: Hypoxanthine],5,4,1,0,0,4,0,0,0,0.8,0.2,2,3.3,6,5,Inf,3,1,Condensed HC,23.46869151,19.04857984,0.81165922,-0.301053965,0.085081444,0.199126785,Downregulated
Feature0471,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,16,0,0,6,0,0,0,1.363636364,0.727272727,0.909090909,34.39090909,11,-5,#NAME?,-0.375,-11,Other,25.57050269,20.67683047,0.808620414,-0.306465469,0.04551393,0.161148715,Downregulated
Feature0470,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,16,0,0,6,0,0,0,1.363636364,0.727272727,0.909090909,34.39090909,11,-5,#NAME?,-0.375,-11,Other,25.58665472,20.64820237,0.806991089,-0.309375351,0.032840957,0.150901486,Downregulated
Feature0370,[Similar to: methyl N-acetylneuraminate],C12 H21 N O9,323.12167,NA,[Similar to: methyl N-acetylneuraminate]-peak2,12,21,9,0,0,1,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.384615385,-7,Carbohydrate,27.27330656,21.72514428,0.796571704,-0.328123862,0.053719223,0.170783657,Downregulated
Feature0419,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,4,0,0,8,0,1,0,1.833333333,0.666666667,2.666666667,-15.7,6,2,1,1,-7,Amino Sugar,23.95197032,18.66434955,0.779240676,-0.359859107,0.01751652,0.150901486,Downregulated
Feature0048,NA,NA,454.10871,NA,Feature0048,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,1,1,Inf,Inf,1,Other,22.37031211,17.0990851,0.764365067,-0.38766625,0.054587192,0.17110782,Downregulated
Feature0189,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,8,0,0,4,0,1,0,1.3,0.8,1,31.8,7,-1,2,-2,-6,Other,24.42663767,18.64929596,0.763481909,-0.389334122,0.048570042,0.161900141,Downregulated
Feature0194,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,1,0,0,4,0,0,0,0.8,0.2,2,3.3,6,5,Inf,3,1,Condensed HC,24.07368722,18.34967226,0.762229404,-0.391702832,0.025648381,0.150901486,Downregulated